Method for producing compound such as c-arylalkoxyglycoside derivative

A method for producing C-arylalkoxy glycoside derivatives by reacting compound (I) with an acid in alcohol (II) and then with a silane compound in the presence of a Lewis acid addresses the low yield issue, achieving high yields of 60% or more.

JP2024169283APending Publication Date: 2024-12-05TOKUYAMA CORP +1
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
JP2023216211
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-24
Filing Date
2023-12-21
Publication Date
2024-12-05

AI Technical Summary

Technical Problem

Existing methods for producing C-arylalkoxy glycoside derivatives face challenges in achieving high yields.

Method used

A method involving the reaction of a compound (I) with an acid in a solvent containing alcohol (II) at specific temperatures, followed by contact with a silane compound in the presence of a Lewis acid, to produce C-arylalkoxy glycoside derivatives in high yield.

Benefits of technology

The method achieves high yields of C-arylalkoxy glycoside derivatives, with yields of 60% or more for both steps, improving the efficiency of the production process.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024169283000001
    Figure 2024169283000001
  • Figure 2024169283000002
    Figure 2024169283000002
  • Figure 2024169283000003
    Figure 2024169283000003
Patent Text Reader

Abstract

To provide a method for producing a compound such as a C-arylalkoxyglycoside derivative in high yield.SOLUTION: In one embodiment, a method for obtaining a C-arylalkoxyglycoside derivative (2B) comprises bringing a compound represented by the formula (1B') in the figure into contact with an acid in a solvent containing an alcohol.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a method for producing a compound such as a C-arylalkoxyglycoside derivative. [Background technology]

[0002] SGLT-2 inhibitors are useful as antidiabetic drugs. In addition, "SGLT-2" means sodium-glucose cotransporter-2. Examples of SGLT-2 inhibitors include canagliflozin (1-(β-D-glycopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene), empagliflozin ((1S)-1,5-anhydro-1-C-{4-chloro-3-[(4-{[(3S)-oxolan-3-yl]oxy}phenyl)methyl]phenyl}-D-glucitol), ipragliflozin ((1S )-1,5-anhydro-1-C-{3-[(1-benzothiophen-2-yl)methyl]-4-fluorophenyl}-D-glucitol-(2S)-pyrrolidine-2-carboxylic acid), dapagliflozin ((2S,3R,4R,5S,6R)-2-[4-chloro-3-(4-ethyloxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol), etc. are known.

[0003] As a method for producing an SGLT-2 inhibitor, a method for synthesizing canagliflozin by deprotecting the protecting group of a 1-(β-D-glycopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene precursor has been proposed (see Patent Document 1). The 1-(β-D-glycopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene precursor is also called a C-arylhydroxyglycoside derivative, and has attracted attention as an intermediate for producing an SGLT-2 inhibitor (Patent Documents 1-2 and Non-Patent Documents 1-3).

[0004] Various methods for producing C-aryl hydroxyglycoside derivatives have been proposed, including, for example, a method in which an aryl lithium is reacted with a D-gluconolactone derivative at an ultralow temperature of -78°C to add an aryl group (Non-Patent Documents 1 and 3), a method in which a turbo Grignard reagent such as ArMgBr·LiCl (Ar represents an aryl group) is reacted with a D-gluconolactone derivative at a low temperature of -20 to -10°C to add an aryl group (Non-Patent Document 2), and a method in which an aryl group is added to a D-gluconolactone derivative at a temperature of about -15°C using a magnesium ate complex obtained from lithium tri-n-butylmagnesate (nBu3MgLi) (Patent Document 2). It has also been reported that coupling occurs when an organic zinc reagent is reacted with a thioester derivative in the presence of a nickel catalyst to obtain a ketone derivative (Non-Patent Documents 4 and 5).

[0005] Remdesivir, represented by the following formula (X), is a compound that can be used as an antiviral drug. Remdesivir exhibits antiviral activity against single-stranded RNA viruses, such as respiratory syncytial virus and coronavirus.

[0006] [ka]

[0007] Patent Document 3 discloses a method for producing remdesivir and its intermediates. Patent Document 3 describes that a hydroxynucleoside represented by the following formula (XII) can be obtained by reacting a lactone represented by the following formula (XI) with a bromopyrazole represented by the following formula (Ar″) at −78° C. in the presence of chlorotrimethylsilane (TMSCl) and n-butyllithium. This hydroxynucleoside can be used as an intermediate for synthesizing remdesivir. In addition, “Bn” represents a benzyl group.

[0008] [ka] [Prior art documents] [Patent documents]

[0009] [Patent Document 1] WO2010 / 043682 publication [Patent Document 2] WO2015 / 012110 publication [Patent Document 3] WO2012 / 012776 publication [Non-patent literature]

[0010] [Non-Patent Document 1] J. Med. Chem. 2008, 51, 1145-1149 [Non-Patent Document 2] Org.Lett.2014,16,4090-4093 [Non-Patent Document 3] J. Org. Chem. 1989, 54, 610-612 [Non-Patent Document 4] Tetrahedron Letters 2002,43,1039-1042 [Non-Patent Document 5] Chem.Eur.J.2018,24,8774-8778 Summary of the Invention [Problem to be solved by the invention]

[0011] The C-aryl alkoxyglycoside derivative can be obtained by a method including a step of obtaining a C-aryl hydroxyglycoside derivative from a gluconolactone derivative and a step of alkoxylating the C-aryl hydroxyglycoside derivative. However, it is difficult to produce the C-aryl hydroxyglycoside derivative in high yield by this method.

[0012] Therefore, there is a need for a method capable of producing compounds such as C-arylalkoxyglycoside derivatives in high yields.

[0013] An object of the present invention is to provide a method for producing compounds such as C-arylalkoxyglycoside derivatives in high yields. [Means for solving the problem]

[0014] The present invention includes the following inventions. [1] Formula (III): [ka] [In the formula, Ar represents an optionally substituted alkyl group, an optionally substituted alkenyl group, an optionally substituted cycloalkyl group, an optionally substituted heterocycloalkyl group, an optionally substituted aryl group, an optionally substituted heteroaryl group, an optionally substituted arylalkyl group, or an optionally substituted arylalkenyl group, R 100 represents an alkyl group which may have a substituent. A method for producing a compound (III) represented by the following formula: The following formula (Ia): [ka] [In the formula, R each independently represents an alkyl group which may have a substituent or an aryl group which may have a substituent; Ar has the same meaning as above.] Compound (Ia) represented by the formula: The following formula (Ib): [ka] [In the formula, R and Ar are as defined above.] Compound (Ib) represented by the formula: Compound (I) selected from Acid, The following formula (II): [ka] [In the formula, R 100 has the same meaning as above.] in a solvent containing an alcohol (II) represented by the following formula (III): [2] The method according to [1], wherein the compound (I) is contacted with the acid in the solvent at a temperature of -80°C or higher and 40°C or lower. [3] The method according to [1] or [2], wherein the alcohol (II) is an alcohol having 1 to 5 carbon atoms. [4] The method according to [3], wherein the alcohol (II) is methanol. [5] The acid is represented by the following formula (IV): [ka] [In the formula, R 200 represents an alkyl group which may have a substituent or an aryl group which may have a substituent. The method according to any one of [1] to [4], wherein the compound (IV) is represented by the following formula: [6] The method according to any one of [1] to [4], wherein the acid is sulfuric acid. [7] Formula (V): [ka] [In the formula, Ar has the same meaning as defined above.] A method for producing a compound (V) represented by A method comprising the steps of producing compound (III) by the method according to any one of [1] to [6], and then contacting the produced compound (III) with a silane compound in the presence of a Lewis acid to produce compound (V). Effect of the Invention

[0015] According to the present invention, there is provided a method for producing compounds such as C-arylalkoxyglycoside derivatives in high yields. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0016] The present invention will be described below. Two or more embodiments described in this specification can be combined, and the combination of two or more embodiments is also included in the present invention.

[0017] <Terminology explanation> The terms used in this specification are explained below. The following explanations are applied throughout this specification unless otherwise specified. The expression "value A to value B" means value A or more and value B or less unless otherwise specified.

[0018] Halogen atoms The halogen atoms are selected from fluorine, chlorine, bromine and iodine atoms.

[0019] Alkyl group The alkyl group has, for example, 1 to 20, preferably 1 to 15, and more preferably 1 to 12 (for example, 1 to 10, 1 to 8, 1 to 6, 1 to 5, 1 to 4, 1 to 3, or 1 to 2). The alkyl group may be linear or branched. A linear alkyl group has 1 or more carbon atoms, and a branched alkyl group has 3 or more carbon atoms.

[0020] Alkenyl group The alkenyl group has, for example, 2 to 20, preferably 2 to 15, and more preferably 2 to 12 (for example, 2 to 10, 2 to 8, 2 to 6, 2 to 5, 2 to 4, or 2 to 3). The alkenyl group may be linear or branched. A linear alkenyl group has 2 or more carbon atoms, and a branched alkenyl group has 3 or more carbon atoms.

[0021] Cycloalkyl group The cycloalkyl group has, for example, 3 to 10 carbon atoms, preferably 3 to 8 carbon atoms, and more preferably 3 to 6 carbon atoms.

[0022] Heterocycloalkyl Groups The heterocycloalkyl group is a monocyclic saturated aliphatic heterocyclic group containing, as a ring-constituting atom, one or more heteroatoms independently selected from the group consisting of oxygen atoms, sulfur atoms, and nitrogen atoms in addition to carbon atoms. The saturated aliphatic heterocyclic group is an aliphatic heterocyclic group in which the ring is constituted only by saturated bonds. The number of heteroatoms is, for example, 1 to 4, preferably 1 to 3, and more preferably 1 or 2. The number of members of the heterocycloalkyl group is, for example, 3 to 8, preferably 4 to 7, more preferably 5 to 7, and even more preferably 5 or 6. Examples of the heterocycloalkyl group include those containing 1 to 2 oxygen atoms, those containing 1 to 2 sulfur atoms, those containing 1 to 2 oxygen atoms and 1 to 2 sulfur atoms, those containing 1 to 4 nitrogen atoms, and those containing 1 to 3 nitrogen atoms and 1 to 2 sulfur atoms and / or 1 to 2 oxygen atoms. The heterocycloalkyl group preferably contains an oxygen atom as a heteroatom. Examples of heterocycloalkyl groups include aziridinyl, oxiranyl, thiiranyl, azetidinyl, oxetanyl, thietanyl, tetrahydrothienyl, tetrahydrofuranyl, pyrrolidinyl, imidazolidinyl, oxazolidinyl, pyrazolidinyl, thiazolidinyl, tetrahydroisothiazolyl, tetrahydrooxazolyl, tetrahydroisoxazolyl, piperidinyl, piperazinyl, tetrahydropyranyl, tetrahydrothiopyranyl, morpholinyl, thiomorpholinyl (wherein the sulfur atom on the ring may be oxidized), azepanyl, diazepanyl, oxepanyl, azocanyl, and diazocanyl groups.

[0023] In one embodiment, the heterocycloalkyl group is selected from tetrahydrofuranyl and tetrahydropyranyl groups. The heterocycloalkyl group is preferably a tetrahydrofuranyl group.

[0024] Aryl Group The aryl group is, for example, a monocyclic or polycyclic (for example, bicyclic or tricyclic) aromatic hydrocarbon ring group having 4 to 14 carbon atoms, preferably 6 to 14, more preferably 6 to 10. The polycyclic group is preferably a condensed ring group. Examples of the aryl group include a phenyl group and a naphthyl group. The aryl group is preferably a phenyl group.

[0025] Heteroaryl Groups The heteroaryl group is a monocyclic or polycyclic (e.g., bicyclic or tricyclic) aromatic heterocyclic group containing, as ring-constituting atoms, one or more heteroatoms independently selected from the group consisting of oxygen atoms, sulfur atoms, and nitrogen atoms in addition to carbon atoms. The polycyclic group is preferably a condensed ring system. The number of heteroatoms is, for example, 1 to 4, preferably 1 to 3, and more preferably 1 or 2. The number of members of the heteroaryl group is preferably 4 to 14, and more preferably 5 to 10. Examples of the heteroaryl group include those containing 1 to 2 oxygen atoms, those containing 1 to 2 sulfur atoms, those containing 1 to 2 oxygen atoms and 1 to 2 sulfur atoms, those containing 1 to 4 nitrogen atoms, and those containing 1 to 3 nitrogen atoms and 1 to 2 sulfur atoms and / or 1 to 2 oxygen atoms. The heteroaryl group is preferably a monocyclic or bicyclic 4 to 10-membered, preferably 5 to 10-membered aromatic heterocyclic group.

[0026] Examples of the monocyclic aromatic heterocyclic group include 5- to 7-membered monocyclic aromatic heterocyclic groups such as a pyridyl group, a pyridazinyl group, a pyrimidinyl group, a pyrazinyl group, a thienyl group, a pyrrolyl group, a thiazolyl group, an isothiazolyl group, a pyrazolyl group, an imidazolyl group, a furyl group, an oxazolyl group, an isoxazolyl group, an oxadiazolyl group (e.g., a 1,2,4-oxadiazolyl group, a 1,3,4-oxadiazolyl group, etc.), a thiadiazolyl group (e.g., a 1,2,4-thiadiazolyl group, a 1,3,4-thiadiazolyl group, etc.), a triazolyl group (e.g., a 1,2,3-triazolyl group, a 1,2,4-triazolyl group, etc.), a tetrazolyl group, and a triazinyl group.

[0027] Examples of the condensed polycyclic aromatic heterocyclic group include a benzothiophenyl group, a benzofuranyl group, a benzimidazolyl group, a benzoxazolyl group, a benzisoxazolyl group, a benzothiazolyl group, a benzisothiazolyl group, a benzotriazolyl group, an imidazopyridinyl group, a thienopyridinyl group, a furopyridinyl group, a pyrrolopyridinyl group, a pyrazolopyridinyl group, an oxazolopyridinyl group, a thiazolopyridinyl group, an imidazopyrazinyl group, an imidazopyrimidinyl group, a thienopyrimidinyl group, a furopyrimidinyl group, a pyrrolopyrimidinyl group, a pyrazolopyrimid ...rimidinyl group, a thiazolopyridinyl group, a pyrrolopyrimidinyl group, a pyrazolopyrimidinyl group, a thiazolopyridinyl group, a pyrazolopyrimidinyl group, a pyrazolopyrimidinyl group, a pyrazolopyrimidinyl group, a pyrazolopyrimidinyl group, a pyrazolopyrimidinyl group, a pyrazolopyrimidinyl group, a pyrazolopyrimidinyl group, a pyrazolopyrimidinyl group, a pyrazolopyrimidinyl group, a pyrazolopyrimidinyl group, a pyrazolopyrimidinyl group, a pyrazolopyrimidinyl group, a pyrazolopyrimidinyl Examples of such aromatic heterocyclic groups include 8-14 membered fused polycyclic (preferably bicyclic or tricyclic) aromatic heterocyclic groups such as a pyrimidinyl group, a thiazolopyrimidinyl group, a pyrazolotriazinyl group, a naphtho[2,3-b]thienyl group, a phenoxathiinyl group, an indolyl group, an isoindolyl group, a 1H-indazolyl group, a purinyl group, an isoquinolyl group, a quinolyl group, a phthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, an α-carbolinyl group, a phenanthridinyl group, an acridinyl group, a phenazinyl group, a phenothiazinyl group, and a phenoxazinyl group.

[0028] In one embodiment, the heteroaryl group is selected from thienyl, benzothiophenyl, furyl, pyrrolyl, imidazolyl and pyridyl groups. The heteroaryl group is preferably selected from thienyl and benzothiophenyl groups.

[0029] Haloalkyl, haloaryl and haloheteroaryl groups The haloalkyl group, haloaryl group and haloheteroaryl group are respectively an alkyl group, an aryl group and a heteroaryl group having one or more halogen atoms, and the explanations regarding the alkyl group, the aryl group and the heteroaryl group are as above. The number of halogen atoms in the haloalkyl group, the haloaryl group or the haloheteroaryl group is, for example, 1 to 3, preferably 1 or 2, and more preferably 1.

[0030] Alkylene, arylene and heteroarylene groups An alkylene group, an arylene group, and a heteroarylene group are divalent functional groups generated by removing one hydrogen atom from an alkyl group, an aryl group, and a heteroaryl group, respectively, and the explanations for the alkyl group, the aryl group, and the heteroaryl group are as described above.

[0031] Haloalkylene groups, haloarylene groups and haloheteroarylene groups A haloalkylene group, a haloarylene group, and a haloheteroarylene group are divalent functional groups generated by removing one hydrogen atom from a haloalkyl group, a haloaryl group, and a haloheteroaryl group, respectively, and the explanations for the haloalkyl group, the haloaryl group, and the haloheteroaryl group are as described above.

[0032] Arylalkyl group The arylalkyl group is an alkyl group having one or more aryl groups, and the explanation of the alkyl group and the aryl group is as above. The number of aryl groups in the arylalkyl group is, for example, 1 to 3, preferably 1 or 2, and more preferably 1.

[0033] Arylalkenyl Group The arylalkenyl group is an alkenyl group having one or more aryl groups, and the explanation regarding the alkenyl group and the aryl group is as described above. The number of aryl groups contained in the arylalkenyl group is, for example, 1 to 3, preferably 1 or 2, and more preferably 1.

[0034] Alkylcarbonyl and arylcarbonyl groups The alkylcarbonyl group and the arylcarbonyl group are groups represented by the formula: -CO-alkyl group and the formula: -CO-aryl group, respectively, and the alkyl group and the aryl group are as described above.

[0035] Alkyloxy groups, haloalkyloxy groups, heterocycloalkyloxy groups, and arylalkyloxy groups The alkyloxy group, the haloalkyloxy group, the heterocycloalkyloxy group and the arylalkyloxy group are groups represented by the formula: -O-alkyl group, the formula: -O-haloalkyl group, the formula: -O-heterocycloalkyl group and the formula: -O-arylalkyl group, respectively, and the alkyl group, the haloalkyl group, the heterocycloalkyl group and the arylalkyl group are as described above.

[0036] Alkylthio groups, haloalkylthio groups, heterocycloalkylthio groups, and arylalkylthio groups. The alkylthio group, the haloalkylthio group, the heterocycloalkylthio group, and the arylalkylthio group are groups represented by the formula: -S-alkyl group, the formula: -S-haloalkyl group, the formula: -S-heterocycloalkyl group, and the formula: -S-arylalkyl group, respectively, and the alkyl group, the haloalkyl group, the heterocycloalkyl group, and the arylalkyl group are as described above.

[0037] Alkyloxycarbonyl group The alkyloxycarbonyl group is a group represented by the formula: -CO-O-alkyl group, and the explanation of the alkyl group is as above. The number of carbon atoms of the alkyl group contained in the alkyloxycarbonyl group is preferably 1 to 10, more preferably 1 to 8, even more preferably 1 to 6, even more preferably 1 to 4, even more preferably 1 to 3, and even more preferably 1 or 2.

[0038] Amino group An amino group has the formula: -NH 2 It is a group represented by the formula (primary amino group).

[0039] Monoalkylamino group A monoalkylamino group has the formula: -NH(-Q 1 )[where, Q 1 represents an alkyl group.], and the alkyl group is as described above. Q 1 The alkyl group represented by the following formula (1) preferably has 1 to 6 carbon atoms, more preferably 1 to 4 carbon atoms, even more preferably 1 to 3 carbon atoms, and even more preferably 1 or 2 carbon atoms.

[0040] Dialkylamino group A dialkylamino group has the formula: -N(-Q 2 )(-Q 3 )[where, Q 2 and Q 3 Each of Q independently represents an alkyl group. Q is a group represented by the formula: 2 Or Q 3 The alkyl group represented by the following formula (1) preferably has 1 to 6 carbon atoms, more preferably 1 to 4 carbon atoms, even more preferably 1 to 3 carbon atoms, and even more preferably 1 or 2 carbon atoms.

[0041] Alicyclic amino group The alicyclic amino group is, for example, a 5- or 6-membered alicyclic amino group, and examples of the 5- or 6-membered alicyclic amino group include a morpholino group, a thiomorpholino group, a pyrrolidin-1-yl group, a pyrazolidin-1-yl group, an imidazolidin-1-yl group, and a piperidin-1-yl group. The alicyclic amino group may contain, in addition to the nitrogen atom having the bond of the alicyclic amino group, a heteroatom (for example, one heteroatom) independently selected from the group consisting of an oxygen atom, a sulfur atom, and a nitrogen atom. The alicyclic amino group is preferably a morpholino group.

[0042] Aminocarbonyl group, monoalkylaminocarbonyl group, dialkylaminocarbonyl group and alicyclic aminocarbonyl group The aminocarbonyl group, the monoalkylaminocarbonyl group, the dialkylaminocarbonyl group and the alicyclic aminocarbonyl group are groups represented by the formula: -CO-amino group, the formula: -CO-monoalkylamino group, the formula: -CO-dialkylamino group and the formula: -CO-alicyclic amino group, respectively, and the explanations regarding the monoalkylamino group, the dialkylamino group and the alicyclic amino group are as described above.

[0043] One or more substituents One or more substituents preferably means 1 to 3 substituents, more preferably 1 or 2 substituents.

[0044] Substituent group α The substituent group α is composed of the following substituents. (α-1) halogen atom (α-2) Nitrile group (α-3) Nitro group (α-4) Amino group (α-5) alkyl group (α-6) Haloalkyl group (α-7) Monoalkylamino group (α-8) Dialkylamino group (α-9) Alicyclic amino group (α-10) Alkyloxycarbonyl group (α-11) Aminocarbonyl group (α-12) Monoalkylaminocarbonyl group (α-13) Dialkylaminocarbonyl group (α-14) Alicyclic aminocarbonyl group (α-15) Hydroxy group optionally protected by a protecting group (α-16) A thiol group which may be protected by a protecting group

[0045] Substituent group β The substituent group β is composed of the following substituents. (β-1) Substituent represented by formula (i) (β-2) Substituent represented by formula (ii)

[0046] The substituent groups α and β will be described below.

[0047] In (α-5), the alkyl group preferably has 1 to 10 carbon atoms, more preferably 1 to 8, even more preferably 1 to 6, even more preferably 1 to 4, even more preferably 1 to 3, and even more preferably 1 or 2 carbon atoms.

[0048] In (α-6), the number of carbon atoms in the haloalkyl group is preferably 1 to 10, more preferably 1 to 8, even more preferably 1 to 6, even more preferably 1 to 4, even more preferably 1 to 3, and even more preferably 1 or 2. The number of halogen atoms in the haloalkyl group is preferably 1 to 3, more preferably 1 or 2, and even more preferably 1.

[0049] (α-15) Hydroxy group optionally protected by a protecting group The hydroxyl group-protecting group is preferably one that can protect the hydroxyl group during the intended reaction and can be detached from the hydroxyl group after the intended reaction is completed. Examples of the hydroxyl group-protecting group include an alkylcarbonyl type protecting group, an arylcarbonyl type protecting group, an arylalkyl type protecting group, an alkyl type protecting group, an arylalkyloxyalkyl type protecting group, an alkyloxyalkyl type protecting group, a silyl type protecting group, an oxycarbonyl type protecting group, an acetal type protecting group, and an aryl type protecting group. These protecting groups may have one or more halogen atoms.

[0050] Examples of the alkylcarbonyl-type protecting group include an alkylcarbonyl group having 2 to 10 carbon atoms which may have one or more substituents. The substituent may be selected from, for example, a halogen atom, a nitro group, a cyano group, a phenyl group, an alkyl group having 1 to 10 carbon atoms (preferably 1 to 8 carbon atoms, more preferably 1 to 6 carbon atoms, and even more preferably 1 to 4 carbon atoms), an alkyloxy group having 1 to 10 carbon atoms (preferably 1 to 8 carbon atoms, more preferably 1 to 6 carbon atoms, and even more preferably 1 to 4 carbon atoms), and an alkyloxycarbonyl group having 2 to 11 carbon atoms (preferably 2 to 9 carbon atoms, more preferably 2 to 7 carbon atoms, and even more preferably 2 to 5 carbon atoms). Examples of the alkylcarbonyl group having 2 to 10 carbon atoms which may have one or more substituents include an acetyl group, a propanoyl group, a butanoyl group, an isopropanoyl group, and a pivaloyl group. The alkylcarbonyl-type protecting group is preferably an alkylcarbonyl group having 2 to 5 carbon atoms, more preferably an acetyl group or a pivaloyl group, and even more preferably an acetyl group.

[0051] Examples of the arylcarbonyl-type protecting group include an arylcarbonyl group having 7 to 11 carbon atoms which may have one or more substituents. Specific examples of the substituent are the same as those of the alkylcarbonyl-type protecting group. Examples of the arylcarbonyl group having 7 to 11 carbon atoms which may have one or more substituents include a benzoyl group, a 4-nitrobenzoyl group, a 4-methyloxybenzoyl group, a 4-methylbenzoyl group, a 4-tert-butylbenzoyl group, a 4-fluorobenzoyl group, a 4-chlorobenzoyl group, a 4-bromobenzoyl group, a 4-phenylbenzoyl group, and a 4-methyloxycarbonylbenzoyl group.

[0052] Examples of the arylalkyl type protecting group include arylalkyl groups having 7 to 11 carbon atoms which may have one or more substituents. Specific examples of the substituents are the same as those of the alkylcarbonyl type protecting group. Examples of the arylalkyl group having 7 to 11 carbon atoms which may have one or more substituents include benzyl group, 1-phenylethyl group, diphenylmethyl group, 1,1-diphenylethyl group, naphthylmethyl group, and trityl group. The arylalkyl type protecting group is preferably a benzyl group.

[0053] Examples of the alkyl-type protecting group include an alkyl group having 1 to 10 carbon atoms which may have one or more substituents. Specific examples of the substituent are the same as those of the alkylcarbonyl-type protecting group. The alkyl-type protecting group is preferably an alkyl group having 1 to 5 carbon atoms which may have one or more substituents, more preferably a methyl group, an ethyl group, or a tert-butyl group, and even more preferably a methyl group.

[0054] Examples of the arylalkyloxyalkyl type protecting group include arylalkyloxyalkyl groups such as an arylalkyloxymethyl group having 8 to 12 carbon atoms which may have one or more substituents, an arylalkyloxyethyl group having 9 to 13 carbon atoms which may have one or more substituents, and an arylalkyloxypropyl group having 10 to 14 carbon atoms which may have one or more substituents. Specific examples of the substituent are the same as those of the alkylcarbonyl type protecting group. Examples of the arylalkyloxyalkyl type protecting group include a benzyloxymethyl group which may have one or more substituents, preferably a benzyloxymethyl group which may be substituted with a halogen atom, a nitro group, a cyano group, a methyl group, or a methyloxy group, more preferably a benzyloxymethyl group.

[0055] Examples of the alkyloxyalkyl type protecting group include alkyloxyalkyl groups such as an alkyloxymethyl group having 2 to 10 carbon atoms which may have one or more substituents, an alkyloxyethyl group having 3 to 10 carbon atoms which may have one or more substituents, and an alkyloxypropyl group having 4 to 10 carbon atoms which may have one or more substituents. Specific examples of the substituent are the same as those of the alkylcarbonyl type protecting group. The alkyloxyalkyl type protecting group is preferably an alkyloxymethyl group having 2 to 10 carbon atoms which may have one or more substituents, more preferably an alkyloxymethyl group having 2 to 6 carbon atoms which may have a halogen atom, a nitro group, a cyano group, a methyloxy group, or an ethyloxy group, and even more preferably a methyloxymethyl group.

[0056] Examples of the silyl-type protecting group include a silyl group having a functional group selected from an alkyl group having 1 to 10 carbon atoms, which may have one or more substituents, an arylalkyl group having 7 to 11 carbon atoms, which may have one or more substituents, and an aryl group having 6 to 10 carbon atoms, which may have one or more substituents. Specific examples of the substituent are the same as those of the alkylcarbonyl-type protecting group. The silyl-type protecting group is preferably a silyl group having a functional group selected from an alkyl group having 1 to 10 carbon atoms and an aryl group having 6 to 10 carbon atoms, more preferably a silyl group having a functional group selected from an alkyl group having 1 to 5 carbon atoms and a phenyl group, and even more preferably a trimethylsilyl group, a triethylsilyl group, a tert-butyldimethylsilyl group, or a tert-butyldiphenylsilyl group.

[0057] Examples of the oxycarbonyl-type protecting group include an alkyloxycarbonyl group having 2 to 10 carbon atoms, which may have one or more substituents, an alkenyloxycarbonyl group having 3 to 10 carbon atoms, which may have one or more substituents, and an arylalkyloxycarbonyl group having 8 to 12 carbon atoms, which may have one or more substituents. Specific examples of the substituent are the same as those of the alkylcarbonyl-type protecting group. The oxycarbonyl-type protecting group is preferably an alkyloxycarbonyl group having 2 to 6 carbon atoms, an alkenyloxycarbonyl group having 3 to 6 carbon atoms, or a benzyloxycarbonyl group, and more preferably a methyloxymethyl group, an allyloxycarbonyl group, or a benzyloxycarbonyl group.

[0058] Examples of the acetal type protecting group include a tetrahydrofuranyl group, a tetrahydropyranyl group, and the like.

[0059] The aryl-type protecting group includes, for example, an aryl group such as a phenyl group.

[0060] The hydroxy group protected by a protecting group is preferably a group represented by the formula: -OQ. Q represents an alkyl group, a haloalkyl group, an aryl group, a haloaryl group, a heterocycloalkyl group, an alkylcarbonyl group, an arylcarbonyl group, or an arylalkyl group. The number of carbon atoms in the group represented by the formula: -OQ is preferably 1 to 10, more preferably 1 to 8. Q is preferably an alkyl group, a heterocycloalkyl group, an alkylcarbonyl group, or an arylalkyl group, and more preferably an ethyl group, a tetrahydrofuranyl group, an acetyl group, or a benzyl group.

[0061] (α-16) A thiol group which may be protected by a protecting group The thiol group protecting group is preferably one that can protect the thiol group during the target reaction and can be detached from the thiol group after the target reaction is completed. Examples of the thiol group protecting group include an alkylcarbonyl type protecting group, an arylcarbonyl type protecting group, an arylalkyl type protecting group, an alkyl type protecting group, an arylalkyloxyalkyl type protecting group, an alkyloxyalkyl type protecting group, a silyl type protecting group, an oxycarbonyl type protecting group, an acetal type protecting group, and an aryl type protecting group. These protecting groups may have one or more halogen atoms. The explanation of these protecting groups is as above.

[0062] The thiol group protected by a protecting group is preferably a group represented by the formula: -SQ, where Q is as described above.

[0063] (β-1) Substituent represented by formula (i) [ka]

[0064] In formula (i), R 11 , R 12 and R 13each independently represents an alkyl group, a haloalkyl group, an aryl group, a haloaryl group, or a hydroxy group which may be protected by a protecting group. The hydroxy group which may be protected by a protecting group is preferably a group represented by the above formula: -OQ. a is 0 or more and 3 or less.

[0065] (β-2) Substituent represented by formula (ii) [ka]

[0066] In formula (ii), V 10 represents an alkylene group, a haloalkylene group, an arylene group, a haloarylene group, a heteroarylene group, a haloheteroarylene group, an ester bond, an ether bond, or a carbonyl group. The number of carbon atoms in the alkylene group and the haloalkylene group is preferably 1 to 10, and more preferably 1 to 8. The number of carbon atoms in the arylene group and the haloarylene group is preferably 4 to 14, and more preferably 6 to 14. The number of carbon atoms in the heteroarylene group and the haloheteroarylene group is preferably 4 to 14. V 10 is preferably an alkylene group, more preferably a methylene group or an ethylene group.

[0067] In formula (ii), b represents 0 or 1. It is preferable that b is 1.

[0068] In formula (ii), W 10 represents an alkylene group, a haloalkylene group, an arylene group, a haloarylene group, a heteroarylene group, a haloheteroarylene group, an ester bond, an ether bond, or a carbonyl group. 10 is preferably a heteroarylene group, more preferably a 5-membered heteroarylene group containing a sulfur atom as a heteroatom, and even more preferably thienylene.

[0069] In formula (ii), c represents 0 or 1. It is preferable that c is 1.

[0070] In formula (ii), X 10 represents a hydrogen atom, an alkyl group which may have a substituent, an aryl group which may have a substituent, or a heteroaryl group which may have a substituent. The alkyl group, the aryl group, and the heteroaryl group may each be unsubstituted or may have one or more substituents. The one or more substituents may each be independently selected from the substituent group α. The one or more substituents are each preferably independently selected from a halogen atom, an alkyl group, a haloalkyl group, an alkyloxy group, a haloalkyloxy group, an alkylthio group, a haloalkylthio group, a heterocycloalkyloxy group, and a heterocycloalkylthio group, more preferably selected from a halogen atom, an alkyloxy group and a heterocycloalkyloxy group having 1 to 3 carbon atoms, and even more preferably selected from a fluorine atom, an ethyloxy group, and a tetrahydrofuranyloxy group. The heterocycloalkyloxy group preferably contains an oxygen atom as a heteroatom. The number of substituents which each of the alkyl group, the aryl group, and the heteroaryl group may have is preferably 1 to 3, more preferably 1 or 2.

[0071] X 10 is preferably an aryl group which may have a substituent or a heteroaryl group which may have a substituent, more preferably an aryl group having a halogen atom, an alkyloxy group or a heterocycloalkyloxy group having 1 to 3 carbon atoms, or an unsubstituted heteroaryl group, and even more preferably a phenyl group having a fluorine atom, an ethyloxy group or a tetrahydrofuranyloxy group, or an unsubstituted benzothiophenyl group. The heterocycloalkyloxy group preferably contains an oxygen atom as a heteroatom.

[0072] ≪Compound (I)≫ Compound (I) is selected from compound (Ia) represented by the following formula (Ia) and compound (Ib) represented by the following formula (Ib).

[0073] [ka]

[0074] [ka]

[0075] In formulae (Ia) and (Ib), R each independently represents an alkyl group which may have a substituent or an aryl group which may have a substituent. The alkyl group and the aryl group are as described above. The alkyl group may be linear or branched. The number of carbon atoms in the alkyl group is preferably 1 to 10, more preferably 1 to 8, even more preferably 1 to 6, even more preferably 1 to 4, and even more preferably 1 to 3. The aryl group is preferably a phenyl group. The alkyl group and the aryl group may each be unsubstituted or may have one or more substituents. The number of substituents that the alkyl group and the aryl group may each have is preferably 1 to 3, more preferably 1 or 2. The one or more substituents may each be independently selected from the substituent groups α and β. One or more substituents may be selected from the substituent group α, and one or more substituents may be selected from the substituent group β. The one or more substituents are each independently preferably selected from a halogen atom, an alkyl group, a haloalkyl group, an alkyloxy group, a haloalkyloxy group, an alkylthio group, and a haloalkylthio group, more preferably selected from a halogen atom, an alkyl group having 1 to 3 carbon atoms, a haloalkyl group having 1 to 3 carbon atoms, an alkyloxy group having 1 to 3 carbon atoms, and a haloalkyloxy group having 1 to 3 carbon atoms, and even more preferably selected from a halogen atom, an alkyl group having 1 to 3 carbon atoms, and an alkyloxy group having 1 to 3 carbon atoms.

[0076] In formulas (Ia) and (Ib), all R (four R in formula (Ia) and five R in formula (Ib)) may not be the same, but are preferably the same from the viewpoint of efficient introduction and removal of the hydroxy-protecting group represented by the formula: -CO-R. In one embodiment, all R are methyl groups. In another embodiment, all R are phenyl groups.

[0077] In formulae (Ia) and (Ib), Ar is (1) an alkyl group which may have a substituent, (2) an alkenyl group which may have a substituent, (3) a cycloalkyl group which may have a substituent, (4) a heterocycloalkyl group which may have a substituent, (5) an optionally substituted aryl group, (6) an optionally substituted heteroaryl group, (7) an arylalkyl group which may have a substituent, or (8) An arylalkenyl group which may have a substituent Represents.

[0078] The functional groups (1) to (8) will be described below.

[0079] (1) An alkyl group which may have a substituent The alkyl group is as described above. The alkyl group may be unsubstituted or may have one or more substituents. The number of substituents is preferably 1 to 3, more preferably 1 or 2. The one or more substituents may be independently selected from the substituent groups α and β. One or more substituents may be selected from the substituent group α, and one or more substituents may be selected from the substituent group β.

[0080] (2) an alkenyl group which may have a substituent The alkenyl group is as described above. The alkenyl group may be unsubstituted or may have one or more substituents. The number of the substituents is preferably 1 to 3, more preferably 1 or 2. The one or more substituents may be independently selected from the substituent groups α and β. One or more substituents may be selected from the substituent group α, and one or more substituents may be selected from the substituent group β.

[0081] (3) an optionally substituted cycloalkyl group The explanation regarding the cycloalkyl group is as above. The cycloalkyl group may be unsubstituted or may have one or more substituents. The number of the substituents is preferably 1 to 3, more preferably 1 or 2. The one or more substituents may be independently selected from the substituent groups α and β. One or more substituents may be selected from the substituent group α, and one or more substituents may be selected from the substituent group β.

[0082] (4) Optionally substituted heterocycloalkyl group The heterocycloalkyl group is as described above. The heterocycloalkyl group may be unsubstituted or may have one or more substituents. The number of the substituents is preferably 1 to 3, more preferably 1 or 2. The one or more substituents may be independently selected from the substituent groups α and β. One or more substituents may be selected from the substituent group α, and one or more substituents may be selected from the substituent group β.

[0083] (5) An aryl group which may have a substituent The aryl group is as described above. The aryl group may be unsubstituted or may have one or more substituents. The number of the substituents is preferably 1 to 3, more preferably 1 or 2. The one or more substituents may be independently selected from the substituent groups α and β. One or more substituents may be selected from the substituent group α, and one or more substituents may be selected from the substituent group β.

[0084] (6) Optionally substituted heteroaryl group The heteroaryl group is as described above. The heteroaryl group may be unsubstituted or may have one or more substituents. The number of the substituents is preferably 1 to 3, more preferably 1 or 2. The one or more substituents may be independently selected from the substituent groups α and β. One or more substituents may be selected from the substituent group α, and one or more substituents may be selected from the substituent group β.

[0085] (7) Arylalkyl group optionally having a substituent The arylalkyl group is as described above. The arylalkyl group may be unsubstituted or may have one or more substituents. The number of the substituents is preferably 1 to 3, more preferably 1 or 2. The one or more substituents may be independently selected from the substituent groups α and β. One or more substituents may be selected from the substituent group α, and one or more substituents may be selected from the substituent group β.

[0086] (8) An arylalkenyl group which may have a substituent The arylalkenyl group is as described above. The arylalkenyl group may be unsubstituted or may have one or more substituents. The number of the substituents is preferably 1 to 3, more preferably 1 or 2. The one or more substituents may be independently selected from the substituent groups α and β. One or more substituents may be selected from the substituent group α, and one or more substituents may be selected from the substituent group β.

[0087] In the functional group (5) (i.e., an aryl group which may have a substituent), it is preferable that the carbon atoms located on both sides of the carbon atom having a bond of the aryl group (i.e., the carbon atom bonded to -CO-) do not have a substituent. The remaining carbon atoms may have a substituent.

[0088] In the functional group (6) (i.e., a heteroaryl group which may have a substituent), it is preferable that the carbon atoms or heteroatoms located on both sides of the carbon atom having a bond of the heteroaryl group (i.e., the carbon atom bonded to -CO-) do not have a substituent. The remaining carbon atoms or heteroatoms may have a substituent.

[0089] In one embodiment, all R are the same (e.g., all R are methyl or phenyl groups) and Ar is functional group (1).

[0090] In another embodiment, all R are the same (e.g., all R are methyl or phenyl groups) and Ar is functional group (2).

[0091] In yet another embodiment, all R are the same (e.g., all R are methyl or phenyl groups) and Ar is functional group (3).

[0092] In yet another embodiment, all R are the same (e.g., all R are methyl or phenyl groups) and Ar is functional group (4).

[0093] In yet another embodiment, all R are the same (e.g., all R are methyl or phenyl groups) and Ar is functional group (5).

[0094] In yet another embodiment, all R are the same (e.g., all R are methyl or phenyl groups) and Ar is functional group (6).

[0095] In yet another embodiment, all R are the same (e.g., all R are methyl or phenyl groups) and Ar is functional group (7).

[0096] In yet another embodiment, all R are the same (e.g., all R are methyl or phenyl groups) and Ar is functional group (8).

[0097] It is preferable that Ar is a functional group represented by the following formula (iv): In one embodiment, all R are the same (e.g., all R are methyl groups or phenyl groups), and Ar is a functional group represented by the following formula (iv).

[0098] [ka]

[0099] In formula (iv), Y 10 represents an alkylene group which may have a substituent, an arylene group which may have a substituent, or a heteroarylene group which may have a substituent. The number of carbon atoms in the alkylene group is preferably 1 to 10, and more preferably 1 to 8. The number of carbon atoms in the arylene group is preferably 4 to 14, and more preferably 6 to 14. The number of carbon atoms in the heteroarylene group is preferably 4 to 14. The alkylene group, the arylene group, and the heteroarylene group may each be unsubstituted or may have one or more substituents. The one or more substituents may each be independently selected from the substituent group α. The one or more substituents are each preferably independently selected from a halogen atom, an alkyl group, a haloalkyl group, an alkyloxy group, a haloalkyloxy group, an alkylthio group, and a haloalkylthio group, and more preferably selected from a halogen atom, an alkyl group having 1 to 3 carbon atoms, and an alkyloxy group having 1 to 3 carbon atoms. The number of substituents that each of the alkylene group, the arylene group, and the heteroarylene group may have is preferably 1 to 3, and more preferably 1 or 2.

[0100] Y 10 is preferably an arylene group having a substituent, more preferably an arylene group having a halogen atom or an alkyl group having 1 to 3 carbon atoms, and even more preferably a phenylene group having a fluorine atom, a chlorine atom or a methyl group.

[0101] Y 10is preferably an arylene group in which the carbon atoms on both sides of the carbon atom bonded to -CO- have no substituents and the remaining carbon atoms may have a substituent, or a heteroarylene group in which the carbon atoms or hetero atoms on both sides of the carbon atom bonded to -CO- have no substituents and the remaining carbon atoms or hetero atoms may have a substituent. 10 is more preferably a phenylene group which has no substituent at the ortho position relative to the carbon atom bonded to --CO-- and which may have substituents at the meta and / or para positions.

[0102] In formula (iv), V 10 , W 10 , X 10 , b and c are defined as in formula (ii).

[0103] Alternatively, Ar is preferably a functional group represented by the following formula (vi): In one embodiment, all R are the same (e.g., all R are methyl groups or phenyl groups), and Ar is a functional group represented by the following formula (vi):

[0104] [ka]

[0105] In formula (vi), R 41 and R 42Each of R independently represents a hydrogen atom or a protecting group for an amino group. As the protecting group for an amino group, any protecting group such as a carbamate, acyl, amide, sulfonamide, or phthaloyl group may be used. As the protecting group for a carbamate group, for example, a tert-butoxycarbonyl group, a benzyloxycarbonyl group, a 9-fluorenylmethyloxycarbonyl group, a 2,2,2-trichloroethoxycarbonyl group, or an allyloxycarbonyl group may be mentioned. As the protecting group for an acyl group, for example, an acetyl group, a pivaloyl group, or a benzoyl group may be mentioned. As the protecting group for an amide group, for example, a trifluoroacetyl group may be mentioned. As the protecting group for a sulfonamide group, for example, a p-toluenesulfonyl group or a 2-nitrobenzenesulfonyl group may be mentioned. As the protecting group for an amino group, it is preferable that the protecting group for an amino group is an acyl or amide protecting group. It is more preferable that the protecting group for an amino group is a pivaloyl or trifluoroacetyl group. R 41 and R 42 may be bonded to each other to form a protecting group for an amino group, such as a phthaloyl group. When Ar has the structure of formula (vi), compound (I) can be suitably used as an intermediate for remdesivir.

[0106] In view of using compounds (Ia) and (Ib) as raw materials for producing an SGLT-2 inhibitor or a derivative thereof, Ar in formulas (Ia) and (Ib) is preferably the same as a functional group possessed by an SGLT-2 inhibitor or a functional group derived from a functional group possessed by an SGLT-2 inhibitor.

[0107] Here, canagliflozin (1-(β-D-glycopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene), empagliflozin ((1S)-1,5-anhydro-1-C-{4-chloro-3-[(4-{[(3S)-oxolan-3-yl]oxy}phenyl)methyl]phenyl}-D-glucitol), ipragliflozin ((1S)-1,5-anhydro-1-C-{3-[(1 SGLT-2 inhibitors, including {4-benzothiophen-2-yl)methyl]-4-fluorophenyl}-D-glucitol-(2S)-pyrrolidine-2-carboxylic acid) and dapagliflozin ((2S,3R,4R,5S,6R)-2-[4-chloro-3-(4-ethyloxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol), have a functional group represented by the following formula (A).

[0108] Therefore, Ar in formulas (Ia) and (Ib) is preferably a functional group represented by the following formula (A): In one embodiment, all R are the same (e.g., all R are methyl groups or phenyl groups), and Ar is a functional group represented by the following formula (A).

[0109] [ka]

[0110] In formula (A), d represents an integer of 0 to 4. d is preferably 1 to 3, more preferably 1 or 2, and even more preferably 1. When d is 2 or more, d R a may be the same or different.

[0111] In formula (A), d R a may each be independently selected from the substituent group α. aare each independently preferably selected from a halogen atom, an alkyl group, a haloalkyl group, an alkyloxy group, a haloalkyloxy group, an alkylthio group, and a haloalkylthio group, and more preferably selected from a halogen atom, an alkyl group having 1 to 3 carbon atoms, and an alkyloxy group having 1 to 3 carbon atoms.

[0112] In formula (A), Ar′ is a functional group represented by the following formula (v).

[0113] [ka]

[0114] In formula (v), W 10 , X 10 and c each have the same meaning as in formula (ii).

[0115] In formula (A), Ar' is preferably a functional group represented by the following formula (Ar'-1), (Ar'-2) or (Ar'-3).

[0116] [ka]

[0117] In formulae (Ar'-1), (Ar'-2) and (Ar'-3), p is an integer of 0 to 5. p is preferably an integer of 0 to 3, more preferably an integer of 0 to 2, and even more preferably 0 or 1.

[0118] In the formulae (Ar'-1), (Ar'-2) and (Ar'-3), p R b are each independently selected from the group consisting of substituent group α, an aryl group which may have one or more substituents selected from the group consisting of substituent group α, and a heteroaryl group which may have one or more substituents selected from the group consisting of substituent group α. bare preferably each independently selected from the group α of substituents and an aryl group which may have one or more substituents selected from the group α of substituents. The one or more substituents selected from the group α of substituents are preferably each independently selected from a halogen atom, an alkyl group, a haloalkyl group, an alkyloxy group, a haloalkyloxy group, an alkylthio group, a haloalkylthio group, a heterocycloalkyloxy group, and a heterocycloalkylthio group, more preferably selected from a halogen atom, an alkyl group having 1 to 3 carbon atoms, an alkyloxy group having 1 to 3 carbon atoms, and a heterocycloalkyloxy group, and even more preferably selected from a fluorine atom, an ethyloxy group, and a tetrahydrofuranyloxy group. The number of substituents which each of the aryl group and the heteroaryl group may have is preferably 1 to 3, more preferably 1 or 2.

[0119] If p is 2 or more, p R b may be the same or different.

[0120] In formula (Ar'-1), p is preferably 1, and R b is preferably a phenyl group which may have a substituent, more preferably a phenyl group having a halogen atom, and even more preferably a phenyl group having a fluorine atom. The position to which the unsubstituted or substituted phenyl group is bonded is preferably the 2-position of the thiophene ring. In the phenyl group having a halogen atom, the position to which the halogen atom is bonded is preferably the 4-position of the benzene ring.

[0121] In formula (Ar'-2), p is preferably 0.

[0122] In formula (Ar'-3), p is preferably 1, and R bis preferably an alkyloxy group which may have a substituent or a heterocycloalkyloxy group which may have a substituent. The alkyloxy group which may have a substituent is preferably an alkyloxy group having 1 to 3 carbon atoms, more preferably a methoxy group or an ethoxy group. The heterocycloalkyloxy group which may have a substituent is preferably a tetrahydrofuranyloxy group. The position to which the alkyloxy group which may have a substituent or the heterocycloalkyloxy group which may have a substituent is bonded is preferably the 4-position of the benzene ring.

[0123] When d=1, the functional group represented by formula (A) is preferably a functional group represented by the following formula (B).

[0124] [ka]

[0125] In formula (B), R a and Ar' have the same meaning as in formula (A).

[0126] The functional group represented by formula (A) or (B) is preferably a functional group represented by the following formula (Ar-1), (Ar-2), (Ar-3) or (Ar-4), where "Et" represents an ethyl group (the same applies throughout this specification).

[0127] [ka]

[0128] In one embodiment, all R are the same (eg, all R are methyl or phenyl groups) and Ar is a functional group represented by formula (Ar-1).

[0129] In another embodiment, all R are the same (eg, all R are methyl or phenyl groups) and Ar is a functional group represented by formula (Ar-2).

[0130] In yet another embodiment, all R are the same (eg, all R are methyl or phenyl groups) and Ar is a functional group represented by formula (Ar-3).

[0131] In yet another embodiment, all R are the same (eg, all R are methyl or phenyl groups) and Ar is a functional group represented by formula (Ar-4).

[0132] Alcohol (II) The alcohol (II) is represented by the following formula (II).

[0133] [ka]

[0134] In formula (II), R 100 represents an alkyl group which may have a substituent. The alkyl group is as described above. The alkyl group may be linear or branched. The number of carbon atoms in the alkyl group is preferably 1 to 10, more preferably 1 to 8, even more preferably 1 to 6, even more preferably 1 to 5, even more preferably 1 to 4, and even more preferably 1 to 3. The alkyl group may be unsubstituted or may have one or more substituents. The number of substituents is preferably 1 to 3, more preferably 1 or 2. The one or more substituents may be independently selected from the substituent groups α and β. One or more substituents may be selected from the substituent group α, and one or more substituents may be selected from the substituent group β. The one or more substituents are each independently preferably selected from a halogen atom, an alkyl group, a haloalkyl group, an alkyloxy group, a haloalkyloxy group, an alkylthio group, and a haloalkylthio group, more preferably selected from a halogen atom, an alkyl group having 1 to 3 carbon atoms, a haloalkyl group having 1 to 3 carbon atoms, an alkyloxy group having 1 to 3 carbon atoms, and a haloalkyloxy group having 1 to 3 carbon atoms, and even more preferably selected from a halogen atom, an alkyl group having 1 to 3 carbon atoms, and an alkyloxy group having 1 to 3 carbon atoms.

[0135] Examples of the alcohol (II) include methanol, ethanol, 1-propanol, isopropanol, 1-butanol, 2-butanol, isobutanol, 2-methyl-2-propanol, 1-pentanol, 2-pentanol, 3-pentanol, 2-methyl-1-butanol, 2-methyl-2-butanol, 3-methyl-1-butanol, 3-methyl-2-butanol, neopentyl alcohol, n-hexanol, 2-hexanol, 3-hexanol, 2-methyl-1-pentanol, Examples of the alcohols include those having 1 to 10 carbon atoms, such as 3-methyl-1-pentanol, 4-methyl-1-pentanol, 2-methyl-2-pentanol, 3-methyl-2-pentanol, 4-methyl-2-pentanol, 2-methyl-3-pentanol, 3-methyl-3-pentanol, 2,2-dimethyl-1-butanol, 2,3-dimethyl-1-butanol, 3,3-dimethyl-1-butanol, 2,3-dimethyl-2-butanol, 3,3-dimethyl-2-butanol, and 2-ethyl-1-butanol.

[0136] ≪Compound (III)≫ Compound (III) is represented by the following formula (III): Compound (III) includes C-arylalkoxyglycoside derivatives.

[0137] [ka]

[0138] In formula (III), Ar has the same meaning as in formulas (Ia) and (Ib).

[0139] In formula (III), R 100 has the same meaning as formula (II).

[0140] ≪Compound (IV)≫ Compound (IV) is represented by the following formula (IV).

[0141] [ka]

[0142] In formula (IV), R 200 represents an alkyl group which may have a substituent or an aryl group which may have a substituent. The alkyl group and the aryl group are as described above. The alkyl group may be linear or branched. The number of carbon atoms in the alkyl group is preferably 1 to 10, more preferably 1 to 8, even more preferably 1 to 6, even more preferably 1 to 4, and even more preferably 1 to 3. The aryl group is preferably a phenyl group. The alkyl group and the aryl group may each be unsubstituted or may have one or more substituents. The number of substituents that the alkyl group and the aryl group may each have is preferably 1 to 3, more preferably 1 or 2. The one or more substituents may each be independently selected from the substituent groups α and β. One or more substituents may be selected from the substituent group α, and one or more substituents may be selected from the substituent group β. The one or more substituents are each independently preferably selected from a halogen atom, an alkyl group, a haloalkyl group, an alkyloxy group, a haloalkyloxy group, an alkylthio group, and a haloalkylthio group, more preferably selected from a halogen atom, an alkyl group having 1 to 3 carbon atoms, a haloalkyl group having 1 to 3 carbon atoms, an alkyloxy group having 1 to 3 carbon atoms, and a haloalkyloxy group having 1 to 3 carbon atoms, and even more preferably selected from a halogen atom, an alkyl group having 1 to 3 carbon atoms, and an alkyloxy group having 1 to 3 carbon atoms.

[0143] R 200 Examples of compound (IV) in which is an alkyl group which may have a substituent include alkylsulfonic acids such as methanesulfonic acid.

[0144] R 200 Examples of the compound (IV) in which is an optionally substituted aryl group include arylsulfonic acids such as p-toluenesulfonic acid and benzenesulfonic acid.

[0145] ≪Compound (V)≫ Compound (V) is represented by the following formula (V).

[0146] [ka]

[0147] In formula (V), Ar has the same meaning as in formulas (Ia) and (Ib).

[0148] <Method for producing compound (III)> The method for producing compound (III) comprises the step of contacting compound (I) with an acid in a solvent containing alcohol (II) to produce compound (III).

[0149] As the compound (I), either the compound (Ia) or (Ib) may be used, or both the compounds (Ia) and (Ib) may be used. As the compound (I), one compound selected from the compounds (Ia) and (Ib) may be used, or two or more compounds selected from the compounds (Ia) and (Ib) may be used.

[0150] When the compound (I) and the acid are contacted in a solvent containing the alcohol (II), the contact temperature is, for example, from -100°C to 50°C, preferably from -80°C to 40°C, more preferably from -75°C to 30°C, and the contact time is, for example, from 0.5 hours to 48 hours, preferably from 1 hour to 24 hours, more preferably from 1 hour to 17 hours. The contact of the compound (I) and the acid in the solvent containing the alcohol (II) can be carried out under an inert atmosphere (for example, under an argon atmosphere or a nitrogen atmosphere).

[0151] When compound (Ia) is used as compound (I), compound (Ia) is contacted with an acid in a solvent containing alcohol (II), and the following steps are successively carried out: cyclization of compound (Ia) to produce compound (C), elimination of the hydroxyl group-protecting group R' from compound (C) to produce compound (D), and alkoxylation of compound (D) to produce compound (III), thereby obtaining compound (III) in high yield. The yield of compound (III) from compound (Ia) is, for example, 60% or more, preferably 70% or more, more preferably 80% or more.

[0152] When compound (Ib) is used as compound (I), compound (Ib) is contacted with an acid in a solvent containing alcohol (II), and the following processes are successively carried out: elimination of the hydroxyl group-protecting group R' from compound (Ib) to produce compound (F), cyclization of compound (F) to produce compound (D), and alkoxylation of compound (D) to produce compound (III), thereby obtaining compound (III) in high yield. The yield of compound (III) from compound (Ib) is, for example, 60% or more, preferably 70% or more, more preferably 80% or more.

[0153] Compound (C) produced by cyclization of compound (Ia) is represented by the following formula (C): In formula (C), R' represents a hydroxy-protecting group represented by the formula: -CO-R, and Ar and R are the same as those in formula (Ia).

[0154] [ka]

[0155] Compound (F) produced by removing the hydroxy-protecting group R' from compound (Ib) is represented by the following formula (F): In formula (F), Ar has the same meaning as in formula (Ib).

[0156] [ka]

[0157] Compound (D) produced by removing the hydroxy-protecting group R' from compound (C) or by cyclizing compound (F) is represented by the following formula (D): In formula (D), Ar has the same meaning as in formulas (Ia) and (Ib).

[0158] [ka]

[0159] The alkoxylation of compound (D) involves the elimination of HO from compound (D) to produce compound (E), and the alkoxylation of compound (E) with the formula: -OR 100 The addition of a group represented by the formula: -OR to compound (E) proceeds successively, and compound (D) is alkoxylated to produce compound (III). The elimination of HO from compound (D) involves an acid, and the addition of a group represented by the formula: -OR to compound (E) leads to compound (III). 100 The addition of the group represented by the formula: involves an alcohol (II).

[0160] Compound (E) produced by elimination of H2O from compound (D) is represented by the following formula (E): In formula (E), Ar has the same meaning as in formulas (Ia) and (Ib).

[0161] [ka]

[0162] Compound (I) may be a commercially available product or may be produced according to a conventional method. Compound (I) may be produced according to a method for which the present patent applicant has filed a patent application (Patent Application No. 2023-214194).

[0163] The acid to be contacted with compound (I) may be selected from, for example, inorganic acids such as hydrochloric acid, sulfuric acid, phosphoric acid, etc.; organic acids such as acetic acid, propionic acid, pivalic acid, etc.; compound (IV), etc. One type of acid may be used alone, or two or more types of acids may be used in combination.

[0164] From the viewpoint of increasing the yield of compound (III), the acid to be contacted with compound (I) is preferably selected from an inorganic acid and compound (IV). The inorganic acid is preferably sulfuric acid. Compound (IV) is preferably selected from methanesulfonic acid, p-toluenesulfonic acid, and benzenesulfonic acid, and more preferably methanesulfonic acid.

[0165] In one embodiment, compound (Ia) is used as compound (I) and compound (IV) (preferably methanesulfonic acid) is used as the acid. In another embodiment, compound (Ib) is used as compound (I) and an inorganic acid (preferably sulfuric acid) is used as the acid.

[0166] The amount of the acid used is, for example, 0.05 to 20 moles, preferably 0.01 to 10 moles, more preferably 0.05 to 5 moles, relative to 1 mole of compound (I). The amount of compound (I) used means the amount of the one compound used when one type of compound is used as compound (I), and means the total amount of the two or more compounds used when two or more types of compounds are used as compound (I) (hereinafter the same). The amount of acid used means the amount of the one acid used when one type of acid is used, and means the total amount of the two or more acids used when two or more types of acids are used.

[0167] The contact between the compound (I) and the acid is carried out in a solvent containing the alcohol (II). The compound (I) and the acid can be contacted in a solvent containing the alcohol (II) by mixing the compound (I) and the acid in a solvent containing the alcohol (II).

[0168] The solvent used for contacting compound (I) with the acid may contain one type of alcohol (II) or may contain two or more types of alcohol (II).

[0169] The alcohol (II) is a monohydric chain aliphatic alcohol. The alcohol (II) may be linear or branched. The number of carbon atoms in the alcohol (II) is, for example, 1 to 10. From the viewpoint of increasing the yield of the compound (III), the number of carbon atoms in the alcohol (II) is preferably 1 to 5, more preferably 1 to 4, even more preferably 1 to 3, and even more preferably 1 or 2. That is, R 100 The alkyl group which may have a substituent, represented by the following formula (1), preferably has 1 to 5 carbon atoms, more preferably 1 to 4 carbon atoms, even more preferably 1 to 3 carbon atoms, and even more preferably 1 or 2 carbon atoms.

[0170] From the viewpoint of increasing the yield of compound (III), the alcohol (II) is preferably selected from methanol, ethanol, 1-propanol, isopropanol, 1-butanol, 2-butanol, isobutanol and 2-methyl-2-propanol, and is more preferably methanol.

[0171] The amount of alcohol (II) used is, for example, 1 mL to 30 mL, preferably 1 mL to 20 mL, more preferably 1 mL to 10 mL, per 1 g of compound (I). When one type of alcohol (II) is used, the amount of the alcohol (II) used means the amount of the one type of alcohol used, and when two or more types of alcohols (II) are used, the amount of the two or more types of alcohols used means the total amount of the two or more types of alcohols used.

[0172] The solvent used for contacting compound (I) with an acid may contain one or more organic solvents other than the alcohol (II). Examples of organic solvents other than the alcohol (II) include polyhydric alcohols such as ethylene glycol, propylene glycol, and glycerin; polyhydric alcohol derivatives such as ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, propylene glycol monomethyl ether, propylene glycol monoethyl ether, ethylene glycol dimethyl ether, ethylene glycol diethyl ether, propylene glycol dimethyl ether, and propylene glycol diethyl ether; ether-based solvents such as tetrahydrofuran (THF), 2-methyl-tetrahydrofuran, cyclopentyl methyl ether, dibutyl ether, 1,4-dioxane, t-butyl methyl ether, diisopropyl ether, dimethoxyethane, and diglyme; ketone-based solvents such as acetone, methyl ethyl ketone, and diethyl ketone; ester-based solvents such as methyl acetate and ethyl acetate; halogenated hydrocarbon-based solvents such as dichloromethane (DCM), chloroform, carbon tetrachloride, 1,2-dichloroethane, and chlorobenzene; aromatic hydrocarbon-based solvents such as toluene and xylene; and aliphatic hydrocarbon-based solvents such as hexane and heptane. The organic solvent may be selected from, for example, ethylene glycol, ethylene glycol monomethyl ether, tetrahydrofuran, 2-methyl-tetrahydrofuran, 1,4-dioxane, 1,2-dimethoxyethane, toluene, xylene, dichloromethane, chloroform, hexane, methyl acetate, and ethyl acetate. From the viewpoint of increasing the yield of compound (III), the organic solvent other than alcohol (II) is preferably tetrahydrofuran.

[0173] From the viewpoint of increasing the yield of compound (III), the solvent used for contacting compound (I) with an acid is preferably a mixed solvent of alcohol (II) and an ether solvent, more preferably a mixed solvent of methanol and tetrahydrofuran.

[0174] The amount of the solvent used to contact compound (I) with the acid is, for example, 1 mL to 100 mL, preferably 2 mL to 50 mL, more preferably 3 mL to 30 mL, per 1 g of compound (I).

[0175] Compound (III) can be isolated from the reaction mixture by a conventional method. For example, after carrying out a step of producing compound (III) by contacting compound (I) with an acid in a solvent containing alcohol (II), compound (III) can be extracted from the reaction mixture obtained by the step to obtain an extract (crude product) containing compound (III), and the obtained extract can be purified to isolate compound (III).

[0176] When extracting compound (III) from the reaction mixture, it is preferable to use an organic solvent as the extraction solvent. One type of organic solvent may be used alone, or two or more types of organic solvents may be used in combination. The organic solvent used to extract compound (III) from the reaction mixture is preferably different from the organic solvent used to contact compound (I) with the acid. The organic solvent used to extract compound (III) from the reaction mixture is preferably ethyl acetate, methyl acetate, dichloromethane, chloroform, methyl t-butyl ether, hexane, toluene, xylene, 1,4-dioxane, ether, dibutyl ether, cyclopentyl methyl ether, or a mixture thereof.

[0177] Compound (III) can be extracted from the reaction mixture, for example, by the following method.

[0178] First, a quenching liquid (e.g., a saturated aqueous solution of sodium bicarbonate, etc.) and an organic solvent, if necessary, are added to the reaction mixture to quench the reaction. The reaction mixture to which the quenching liquid and, if necessary, the organic solvent are added is stirred to separate into an aqueous layer and an organic layer (hereinafter referred to as "organic layer (A)"). After the organic layer (A) is removed, an organic solvent is added to the aqueous layer to separate it again into an aqueous layer and an organic layer (hereinafter referred to as "organic layer (B)", and the organic layer (B) may be removed and combined with the organic layer (A) previously removed to obtain a total organic layer. Next, a residue containing compound (III) is obtained from the organic layer (A) or the total organic layer. For example, the organic layer (A) or the total organic layer is washed with a washing liquid (e.g., water, etc.), dried with sodium sulfate, etc., filtered, etc., as necessary, and then concentrated under reduced pressure to obtain a residue containing compound (III). The residue containing compound (III) thus obtained is an example of an extract (crude product) containing compound (III).

[0179] Examples of purification treatments that can be performed on the extract include silica gel column chromatography, recrystallization, trituration, and the like.

[0180] Silica gel column chromatography can be carried out according to a conventional method.

[0181] The recrystallization can be carried out using two kinds of solvents. The two kinds of solvents are selected so that they dissolve in each other (i.e., are compatible). Of the two kinds of solvents, one solvent is a solvent that has a high dissolving ability for compound (III) (hereinafter referred to as "first solvent"), and the other solvent is a solvent that has a low dissolving ability for compound (III) (hereinafter referred to as "second solvent").

[0182] Examples of the first solvent include methyl acetate, ethyl acetate, dichloromethane, chloroform, methyl tert-butyl ether, etc. The first solvent is preferably methyl tert-butyl ether.

[0183] The second solvent may be, for example, heptane, hexane, etc. The second solvent is preferably heptane or hexane.

[0184] Examples of combinations of the first solvent and the second solvent include ethyl acetate / hexane, ethyl acetate / heptane, methyl acetate / hexane, dichloromethane / hexane, chloroform / hexane, methyl tert-butyl ether / hexane, and methyl tert-butyl ether / heptane. Of these, methyl tert-butyl ether / hexane or methyl tert-butyl ether / heptane is preferred.

[0185] The recrystallization treatment of the extract may be carried out by adding the first solvent to the extract, then adding the second solvent, stirring, and then allowing to stand, or by adding a mixture of the first and second solvents to the extract, stirring, and then allowing to stand. The volume ratio of the amount of the first solvent to the amount of the second solvent used (amount of the first solvent used / amount of the second solvent used) is, for example, 1 / 1 to 1 / 10. The stirring time and the time of allowing to stand can be appropriately adjusted.

[0186] The crystals of compound (III) produced by the recrystallization treatment can be isolated by solid-liquid separation. Examples of the solid-liquid separation method include filtration and decantation. The isolated crystals of C-arylhydroxyglycoside (II) may be subjected to treatments such as washing and drying.

[0187] Trituration can be carried out using a mixture of a first solvent and a second solvent. Examples of combinations of the first solvent and the second solvent include ethyl acetate / hexane, ethyl acetate / heptane, methyl acetate / hexane, dichloromethane / hexane, chloroform / hexane, methyl tert-butyl ether / hexane, methyl tert-butyl ether / heptane, etc., among which methyl tert-butyl ether / hexane or methyl tert-butyl ether / heptane is preferred. The volume ratio of the first solvent to the second solvent in the mixture of the first solvent and the second solvent (volume of the first solvent / volume of the second solvent) is, for example, 1 / 1 to 1 / 10, preferably 1 / 1 to 1 / 5.

[0188] The structure of compound (III) can be confirmed, for example, by nuclear magnetic resonance (NMR) spectroscopy.

[0189] <Method for producing compound (V)> The method for producing compound (V) includes the steps of producing compound (III) by the above-mentioned method, and then contacting the produced compound (III) with a silane compound in the presence of a Lewis acid to produce compound (V).

[0190] When compound (III) is contacted with a silane compound in the presence of a Lewis acid, the contact temperature is, for example, from -80°C to 20°C, preferably from -60°C to 10°C, more preferably from -50°C to 0°C, and the contact time is, for example, from 0.5 hours to 4 hours, preferably from 0.5 hours to 3 hours, more preferably from 0.5 hours to 2 hours. The contact of compound (III) with a silane compound in the presence of a Lewis acid can be carried out under an inert atmosphere (for example, under an argon atmosphere or a nitrogen atmosphere).

[0191] The silane compound acts as a reducing agent. Therefore, when the compound (III) is contacted with the silane compound in the presence of a Lewis acid, the reduction reaction of the compound (III) proceeds to produce the compound (V). The yield of the compound (V) from the compound (III) is, for example, 60% or more, preferably 70% or more, more preferably 80% or more.

[0192] Examples of the silane compound include triethylsilane, triisopropylsilane, phenylsilane, dimethylphenylsilane, tert-butyldimethylsilane, triisobutylsilane, trichlorosilane, trimethoxyhydrosilane, triethoxyhydrosilane, tetramethyldisiloxane, etc. One type of silane compound may be used alone, or two or more types of silane compounds may be used in combination.

[0193] From the viewpoint of increasing the yield of compound (V), the silane compound is preferably selected from triethylsilane and triisopropylsilane, and more preferably triethylsilane.

[0194] The amount of the silane compound used is, for example, 1 to 3 moles, preferably 1 to 2 moles, more preferably 1 to 1.5 moles, relative to 1 mole of compound (III). When one type of silane compound is used, the amount of the silane compound used means the amount of the one type of silane compound used, and when two or more types of silane compounds are used, the amount of the two or more types of silane compounds used means the total amount of the two or more types of silane compounds used.

[0195] The contact of compound (III) with the silane compound is carried out in the presence of a Lewis acid.

[0196] Examples of Lewis acids include BF3·Et2O (boron trifluoride diethyl ether complex), BF3·THF (boron trifluoride tetrahydrofuran), AlCl3, ZnCl2, FeCl3, titanium compounds, etc. One type of Lewis acid may be used alone, or two or more types of Lewis acids may be used in combination.

[0197] Known titanium compounds include those in which titanium is zero-valent, divalent, trivalent, and tetravalent, and any of these may be used. Examples of titanium compounds include tetravalent titanium salts or solvates thereof, such as triisopropoxy titanium monochloride (IV), diisopropoxy titanium dichloride (IV), monoisopropoxy titanium trichloride (IV), titanium chloride (IV), titanium bromide (IV), titanium iodide (IV), and titanium oxide (IV); trivalent titanium salts or solvates thereof, such as titanium chloride (III) and titanium bromide (III); divalent titanium salts or solvates thereof, such as titanium chloride (II); and zero-valent titanium or solvates thereof, such as metal Ti. Examples of solvates include those in which a solvent, such as water or tetrahydrofuran, is coordinated.

[0198] Titanium compounds have the formula: TiR c r (OR d ) s [In the formula, R c is a halogen atom, and R d R is a substituted or unsubstituted alkyl group, and r and s are integers of 0 to 4 such that r+s=3 or 4. c is preferably a chlorine atom, a bromine atom or an iodine atom, R d is preferably an alkyl group having 1 to 6 carbon atoms, and more preferably an alkyl group having 1 to 3 carbon atoms.

[0199] The titanium compound is preferably triisopropoxy titanium(IV) monochloride, diisopropoxy titanium(IV) dichloride, monoisopropoxy titanium(IV) trichloride, titanium(IV) chloride, titanium(III) chloride, etc., and more preferably titanium(IV) chloride. Titanium(IV) chloride is preferred because it has a low melting point and is liquid at room temperature, making it easy to handle and inexpensive.

[0200] From the viewpoint of increasing the yield of compound (V), the Lewis acid is preferably BF3·Et2O.

[0201] The amount of Lewis acid used is, for example, 0.1 to 5 moles, preferably 0.5 to 4 moles, more preferably 1 to 3 moles, relative to 1 mole of compound (III). The amount of Lewis acid used means the amount of one Lewis acid used when one type of Lewis acid is used, and means the total amount of two or more Lewis acids used when two or more types of Lewis acids are used.

[0202] The contact of compound (III) with the silane compound in the presence of a Lewis acid is preferably carried out in a solvent. Compound (III), the silane compound, and the Lewis acid can be mixed in a solvent to bring compound (III) into contact with the silane compound in the presence of a Lewis acid. The solvent is preferably selected from organic solvents. One type of organic solvent may be used alone, or a mixed solvent of two or more types of organic solvents may be used. Examples of organic solvents include monohydric alcohols such as methanol, ethanol, 1-propanol, isopropanol, 1-butanol, 2-butanol, isobutanol, and 2-methyl-2-propanol; polyhydric alcohols such as ethylene glycol, propylene glycol, and glycerin; polyhydric alcohols such as ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, propylene glycol monomethyl ether, propylene glycol monoethyl ether, ethylene glycol dimethyl ether, ethylene glycol diethyl ether, propylene glycol dimethyl ether, and propylene glycol diethyl ether. Examples of the organic solvent include alcohol derivatives, ether solvents such as tetrahydrofuran (THF), 2-methyl-tetrahydrofuran, cyclopentyl methyl ether, dibutyl ether, 1,4-dioxane, t-butyl methyl ether, diisopropyl ether, dimethoxyethane, and diglyme, ketone solvents such as acetone, methyl ethyl ketone, and diethyl ketone, ester solvents such as methyl acetate and ethyl acetate, halogenated hydrocarbon solvents such as dichloromethane (DCM), chloroform, carbon tetrachloride, 1,2-dichloroethane, and chlorobenzene, aromatic hydrocarbon solvents such as toluene and xylene, and aliphatic hydrocarbon solvents such as hexane and heptane. The organic solvent may be selected from, for example, ethylene glycol, ethylene glycol monomethyl ether, tetrahydrofuran, 2-methyl-tetrahydrofuran, 1,4-dioxane, 1,2-dimethoxyethane, toluene, xylene, dichloromethane, chloroform, hexane, methyl acetate, and ethyl acetate. From the viewpoint of increasing the yield of compound (V), the organic solvent is preferably dichloromethane.

[0203] The amount of the solvent used in contacting compound (III) with a silane compound in the presence of a Lewis acid is, for example, 2 mL or more and 100 mL or less, preferably 3 mL or more and 50 mL or less, and more preferably 5 mL or more and 10 mL or less, relative to 1 g of compound (III).

[0204] Compound (V) can be isolated from the reaction mixture according to a conventional method. For example, after carrying out a step of producing compound (V) by contacting compound (III) with a silane compound in the presence of a Lewis acid, compound (V) can be extracted from the reaction mixture obtained by the step to obtain an extract (crude product) containing compound (V), and the obtained extract can be purified to isolate compound (V).

[0205] When extracting compound (V) from the reaction mixture, an organic solvent is preferably used as the extraction solvent. One type of organic solvent may be used alone, or two or more types of organic solvents may be used in combination. The organic solvent used to extract compound (V) from the reaction mixture is preferably different from the organic solvent used to contact compound (III) with the silane compound in the presence of Lewis acid. The organic solvent used to extract compound (V) from the reaction mixture is preferably ethyl acetate, methyl acetate, dichloromethane, chloroform, methyl t-butyl ether, hexane, toluene, xylene, 1,4-dioxane, ether, dibutyl ether, cyclopentyl methyl ether, or a mixture thereof.

[0206] Compound (V) can be extracted from the reaction mixture, for example, by the following method.

[0207] First, a quenching liquid (e.g., a saturated aqueous solution of sodium bicarbonate, etc.) and an organic solvent, if necessary, are added to the reaction mixture to quench the reaction. The reaction mixture to which the quenching liquid and, if necessary, the organic solvent are added is stirred to separate into an aqueous layer and an organic layer (hereinafter referred to as "organic layer (C)"). After the organic layer (C) is removed, an organic solvent is added to the aqueous layer to separate it again into an aqueous layer and an organic layer (hereinafter referred to as "organic layer (D)"). The organic layer (D) may be removed and combined with the organic layer (C) previously removed to obtain a total organic layer. Next, a residue containing compound (V) is obtained from the organic layer (C) or the total organic layer. For example, the organic layer (C) or the total organic layer may be washed with a washing liquid (e.g., water, etc.), dried with sodium sulfate, etc., filtered, etc., as necessary, and then concentrated under reduced pressure to obtain a residue containing compound (V). The residue containing compound (V) thus obtained is an example of an extract (crude product) containing compound (V).

[0208] Examples of purification treatments performed on the extract include silica gel column chromatography, recrystallization, trituration, etc. The explanations regarding silica gel column chromatography, recrystallization, and trituration are the same as those described above. EXAMPLES

[0209] In the following Production Examples and Examples, "Ac" represents an acetyl group, "Et" represents an ethyl group, and "Me" represents a methyl group.

[0210] Example 1 Compound (2A) was produced from compound (1A) according to the following reaction scheme: Compound (1A) is (2R,3R,4S,5R)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-2-hydroxy-6-oxohexane-1,3,4,5-tetrayltetraacetate, and compound (2A) is (3R,4S,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol, i.e., a canagliflozin intermediate.

[0211] [ka]

[0212] To a solution of compound (1A) (500 mg, 0.79 mmol, 1 equiv) in tetrahydrofuran (THF) (2.5 mL, 5 vol) was added a solution of methanesulfonic acid (MSA) (382 mg, 3.98 mmol, 5 equiv) in methanol (MeOH) (5 mL, 10 vol) at -70°C. The reaction mass was kept at -70°C for 7 hours and then at room temperature (RT) for 16 hours. Completion of the reaction was confirmed by TLC. The reaction mixture was quenched by adding ethyl acetate (10 mL) and saturated aqueous sodium bicarbonate solution. The organic layer was separated, washed with water (10 mL), dried over sodium sulfate, and filtered. The filtrate was concentrated by vacuum to obtain crude compound. The crude compound was purified by trituration three times with hexane / methyl tert-butyl ether (MTBE) (total 1.1 mL, volume ratio 4 / 1) to obtain 358 mg (yield from compound (1A): 95%) of compound (2A) as a white solid. The obtained compound (2A) was used in the next step without further purification.

[0213] The analytical results of the obtained compound (2A) are shown below.

[0214] FTIR(NaCl):3393,2926,2855,1554,1508,1436,1232,198,1071,1028,832,801,757cm -1 1 H NMR(500MHz,DMSO-d6) δ(ppm):7.57-7.52(m,2H),7.39(d,J=1.4Hz,1H),7.29(dd,J=7.9,1.7Hz,1H),7.24(d,J=3.6Hz,1H),7.17(dd,J=9.9,7.8Hz,2H),7.11(d,J=8.0Hz,1H),6.73(d,J=3.6Hz,1H),4.93(d,J=5.5Hz,1H),4.67(dd,J=24.4,6.2Hz,2H),4.50(dd,J=6.5,5.5Hz,1H),4.12(dt,J=45.4,18.8Hz,2H),3.72(ddd,J=11.5,5.2,1.7Hz,1H),3.60-3.46(m,2H),3.41-3.33(m,1H),3.23-3.14(m,1H),2.92(s,3H),2.90-2.83(m,1H),2.22(s,3H),1.20(s,1H) 13 C{ 1 H} NMR(126MHz,DMSO-d6,30℃) δ(ppm):161.57(d, 1 J C-F =244.4Hz),144.03(d, 5 J C-F =1.4Hz),140.38,137.45,137.15,135.36,130.75(d, 4 J C-F =3.3Hz),129.63,128.99,127.14(d, 3 J C-F =8.2Hz),126.42,126.29,123.61,116.11(d, 2 J C-F =22.68Hz),101.08,77.25,74.55,74.05,70.40,61.13,48.42,33.87,18.94 19 F NMR(471MHz,DMSO-d6,30℃) δ(ppm):114.98 HRMS: [M+Na] + C 25 H 27 FNaO6S Calculated value: 497.1410, Measured value: 497.1405

[0215] Example 2 Compound (3A) was produced from compound (2A) according to the following reaction scheme: Compound (3A) is (2S,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, i.e., canagliflozin.

[0216] [ka]

[0217] To a solution of compound (2A) (300 mg, 0.632 mmol, 1.0 equiv.) in dichloromethane (DCM) (3 mL, 10-fold volume), triethylsilane (TES) (165.4 mg, 1.422 mmol, 2.25 equiv.) was slowly added at -45°C, followed by 48% boron trifluoride diethyl ether complex (BF3·Et2O) (374 mg, 1.264 mmol, 2.0 equiv.) slowly added at -45°C over 30 min. The resulting mixture was stirred at -45°C for 2 h and then maintained at 0°C for 1 h. Completion of the reaction was confirmed by TLC. The reaction was quenched by adding saturated aqueous sodium bicarbonate (5 mL) to the reaction mixture to adjust the pH to 7-8. The organic layer was separated, washed with water (5 mL), dried over sodium sulfate, and filtered. The filtrate was concentrated by vacuum at 40-50° C. to obtain a crude residue. The crude residue was purified by silica gel column chromatography (methanol / dichloromethane=0.2 / 9.8-0.5 / 9.5) to obtain 227 mg (yield from compound (2A): 81%) of compound (3A) as a white solid.

[0218] The analytical results of the obtained compound (3A) are shown below. Melting point (Mp): 114-118℃ FTIR(NaCl):3377.2924.1509.1231.1095.955.896.832cm -1 1 H NMR (500MHz, DMSO-d6) δ(ppm): 7.64-7.56(m,2H), 7.27(d,J=3.6Hz,1H),7.24-7.17(m,3H),7.16-7.09(m,2H),6 .80(d,J=3.6Hz,1H),4.96(d,J=5.0Hz,2H),4.76(d,J=5.8Hz,1H),4.47(t,J=5.8Hz,1H), 4.12(q,J=15.9Hz,2H),3.97(d,J=9.4Hz,1H),3.70(ddd,J=11.7,5.4,1.8Hz,1H),3.45(d). d,J=11.9,5.9Hz,1H),3.30-3.20(m,2H),3.17(ddd,J=14.5,6.1,3.0Hz,2H),2.26(s,3H) 13 C{ 1 H} NMR(126MHz,DMSO-d6.30°C) δ(ppm):161.91(d, 1 J C-F =244.4Hz), 144.17(d, 5 J C-F =1.3Hz),140.76,138.76,137.93,135.51,131.05(d, 4 J C-F =3.4Hz), 130.21,129.60,127.49(d, 3 J C-F =8.2Hz),126.92,126.80,123.93,116.44(d, 2 J C-F =21.42Hz), 81.86,81.74,79.01,75.22,70.94,61.95,33.98,19.36 19 F NMR(471MHz,DMSO-d6.30°C) δ(ppm):114.97 HRMS:[M+Na] + C 24 H 25 NaFO5S Soc: 467.1304, Structure: 467.1299

[0219] Example 3 Compound (2B) was produced from compound (1B) according to the following reaction scheme: Compound (2B) is (2S,3R,4S,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol, i.e., a dapagliflozin intermediate.

[0220] [ka]

[0221] A solution of methanesulfonic acid (MSA) (95 mg, 2.5338 mmol, 5 eq) in methanol (MeOH) (3 mL) was added dropwise to a solution of compound (1B) (300 mg, 0.5068 mmol, 1 eq) in tetrahydrofuran (THF) (1.5 mL) at -78°C, and the mixture was stirred at -78°C for 2 hours, then slowly brought to room temperature (RT) and stirred at room temperature for 12 hours. Completion of the reaction was confirmed by TLC. Ethyl acetate (10 mL) and an aqueous solution of sodium bicarbonate (10 mL) were added to the reaction mixture to quench the reaction. The organic layer was separated, dried over sodium sulfate, and filtered. The filtrate was concentrated by vacuum pumping to obtain a pale yellow solid. The obtained solid was dissolved in methyl tert-butyl ether (MTBE) (2 mL), and recrystallized by adding n-pentane (5 mL). The obtained white solid was filtered and dried to obtain 212 mg (yield from compound (1B): quantitative yield) of compound (2B) as a white solid. The obtained compound (2B) was used in the next step without further purification.

[0222] The analytical results of the obtained compound (2B) are shown below. 1H NMR(500MHz,DMSO-d6) δ(ppm):7.33(s,1H),7.23(dd,J=14.2,7.4Hz,2H),7.01(d,J=8.4Hz,2H), 6.73(d,J=8.4Hz,2H),4.89(d,J=87.6Hz,2H),4.01-3.94(m,2H),3.91(dd, J=13.9,6.8Hz,3H),3.82(d,J=13.5Hz,3H),3.56(s,1H),3.50(d,J=9.5Hz, 1H),3.17(t,J=8.5Hz,1H),2.92(s,1H),2.88(s,3H),1.33(t,J=6.9Hz,3H) 13 C NMR(126MHz,DMSO-d6,30℃) δ(ppm):157.40,138.70,136.61,134.48,131.42,130.06,129.73,129.35,126.7 3,114.47,101.05,74.80,72.52,70.10,63.45,62.06,49.30,38.56,27.07,14.94

[0223] Example 4 Compound (3B) was produced from compound (2B) according to the following reaction formula. Compound (3B) is dapagliflozin.

[0224] [ka]

[0225] Under an argon atmosphere, triethylsilane (TES) (96μL, 0.4566mmol, 2eq) was added dropwise to a dichloromethane (DCM) solution (1mL) of compound (2B) (100mg, 0.2283mmol, 1eq) at -40℃, and then boron trifluoride diethyl ether complex (BF3·Et2O) (95mg, 0.4566mmol, 2eq) was added dropwise at -40℃, and the mixture was stirred at -40℃ for 1 hour. Completion of the reaction was confirmed by TLC. Ethyl acetate (10mL) and aqueous sodium carbonate solution (10mL) were added to the reaction mixture to quench the reaction. The organic layer was separated, dried over sodium sulfate, and filtered. The filtrate was concentrated by vacuum pumping to obtain a pale yellow solid. The obtained solid was dissolved in methyl tert-butyl ether (MTBE) (1mL), and recrystallized by adding n-pentane (3mL). The resulting white solid was filtered off and dried to obtain 86 mg (yield from compound (2B): 93%) of compound (3B) as a white solid.

[0226] The analytical results of the obtained compound (3B) are shown below. 1 H NMR(500MHz,DMSO-d6) δ(ppm):7.33(d,J=8.2Hz,1H),7.29(d,J=1.9Hz,1H),7.19(dd,J=8.2,1.9Hz,1H),7.05(t,J=5.8Hz,2H),6.79(d,J=8.6Hz,2H),4.94(t,J=4.8Hz,1 H),4.81(t,J=6.0Hz,1H),4.43(t,J=5.8Hz,1H),3.96-3.88(m,5H),3.69 -3.61(m,1H),3.43-3.36(m,1H),3.24-3.02(m,3H),1.26(t,J=7.0Hz,3H)

[0227] <Production Example 1> According to the following reaction scheme, compound (5) was produced from compound (4), and compound (1B') was produced from compound (5). Compound (4) is (2R,3S,4R,5R)-2,3,4,5,6-pentaacetoxyhexanoic acid, compound (5) is (2R,3R,4S,5R)-6-chloro-6-oxohexane-1,2,3,4,5-pentyl pentaacetate, and compound (1B') is (2R,3R,4S,5R)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-oxohexane-1,2,3,4,5-pentyl pentaacetate.

[0228] [ka]

[0229] To a solution (3 mL) of compound (4) (250 mg, 0.615 mmol, 1.0 equiv.) in dichloromethane (DCM), N,N-dimethylformamide (DMF) (just 2-3 drops, ca. 0.05 equiv.) was added, followed by oxalyl chloride (COCl)2 (156 mg, 1.231 mmol, 2.0 equiv.) at 0°C. The reaction mixture was stirred at room temperature under argon atmosphere for 2 h. The progress of the reaction was monitored by TLC. The reaction mixture was evaporated and co-distilled with toluene (2.0 mL). Finally, the residue was dried by vacuum for 2 h to obtain compound (5). The obtained compound (5) was used as it was in the next operation.

[0230] In an oven-dried Schlenk tube, 1,2-dibromoethane (0.050 mL, just 1-2 drops) was added to a mixture containing magnesium turnings (30 mg, 1.231 mmol, 2.0 equiv.) and tetrahydrofuran (THF) (3 mL, 10 volumes) under argon atmosphere. Then, 4-bromo-1-chloro-2-(4-ethoxybenzyl)benzene (200 mg, 0.615 mmol, 1.0 equiv.) was added under argon atmosphere. The reaction mixture was then refluxed at 75-80°C for 3 hours. After cooling to room temperature, the reaction mixture was transferred to another Schlenk tube using THF (1 mL x 2). Thus, the Grignard reagent was prepared.

[0231] In another oven-dried Schlenk tube, a THF solution of compound (5) (2 mL x 1) was added to a suspension of CuCN (55 mg, 0.615 mmol, 1.0 equiv.) and THF (1 mL) at -15°C. The Grignard reagent prepared above was then added dropwise to the reaction mixture over 30 min at -15°C and stirred at -15°C for 1 h. The progress of the reaction was monitored by TLC. The reaction was quenched with water (0.5 mL, 2 volumes). The reaction mixture was filtered through a Celite pad and the bed was washed with ethyl acetate (10 mL x 2). The filtrate was dried over anhydrous sodium sulfate and filtered. The solvent was removed by vacuum to obtain the crude compound. The crude compound was purified by silica gel column chromatography (ethyl acetate / n-hexane = 1 / 9 to 4 / 6) to obtain 300 mg (77% yield) of compound (1B') as an off-white fluffy solid.

[0232] The analytical results of the obtained compound (1B') are shown below. 1H NMR(500MHz, CDCl3, 25℃):δ 7.74(d,J=2.1Hz,1H),7.70(dd,J=8.3,2.2Hz,1H),7.47(d,J=8.3Hz,1H),7.12-7.07(m,2H),6. 84-6.80(m,2H),6.00(d,J=5.1Hz,1H),5.67(dd,J=5.0,4.3Hz,1H),5.44(dd,J=7.0,4.3Hz,1H), 5.09(ddd,J=7.0,5.8,2.9Hz,1H),4.29(dd,J=12.5,2.9Hz,1H),44.08(dd,J=12.1,5.9Hz,3H),4 .00(q,J=7.0Hz,2H),2.10(s,3H),2.05(s,3H),2.04(s,3H),2.04(s,3H),1.93(s,3H),1.39(t,J 7.0Hz,3H). 13 C NMR(126MHz, CDCl3, 25℃):δ 192.35,170.65,169.81,169.64,169.63,169.44,157.63,140.14,133.50,130.93,130.41,130.06,129.87, 127.42,114.60,72.32,69.27,68.64,68.50,63.38,61.71,38.30,20.73,20.66,20.49,20.35,20.28,14.83.

[0233] Example 5 Compound (2B) was produced from compound (1B') according to the following reaction scheme: Compound (2B) is (2S,3R,4S,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol, i.e., a dapagliflozin intermediate.

[0234] [ka]

[0235] A solution of sulfuric acid (H2SO4) (67μL, 1.259mmol) in methanol (MeOH) (2mL) was added dropwise to a solution of compound (1B') (100mg, 0.157mmol) in tetrahydrofuran (THF) (1mL) at -15℃, and the mixture was stirred at -15℃ for 2 hours, then slowly brought to room temperature (RT) and stirred at room temperature for 12 hours. Completion of the reaction was confirmed by TLC. Ethyl acetate (10mL) and saturated aqueous sodium bicarbonate solution (10mL) were added to the reaction mixture to quench the reaction. The organic layer was separated, dried over sodium sulfate, and concentrated by vacuum pumping to obtain a crude product as a sticky off-white solid. The obtained crude product was purified by column chromatography (methanol / chloroform=0.5 / 9.5) to obtain 38mg (yield 56%) of compound (2B) as an off-white amorphous solid.

[0236] The analytical results of the obtained compound (2B) are shown below. 1 H NMR (500MHz, CDCl3, 25°C): δ 7.35(s,1H),7.23(s,2H),7.01(d,J=8.7Hz,2H),6.72(d,J=8.7Hz,2H),5.35 (s,1H),5.20(s,1H),4.25(d,J=7.3Hz,1H),4.00-3.92(m,2H),3.93-3.87(m ,2H),3.80(dt,J=24.6,10.0Hz,3H),3.56(t,J=9.4Hz,1H),3.47(d,J=9.8Hz ,1H),3.31(s,1H),3.18(t,J=8.1Hz,2H),2.85(s,3H),1.32(t,J=7.0Hz,3H).

[0237] <Production Example 2> According to the following reaction scheme, compound (5) was produced from compound (4), and compound (1C') was produced from compound (5). Compound (1C') is (2R,3R,4S,5R)-6-(3-(benzo[b]thiophen-2-ylmethyl)-4-fluorophenyl)-6-oxohexane-1,2,3,4,5-pentyl pentaacetate.

[0238] [ka]

[0239] To a solution (3 mL) of compound (4) (250 mg, 0.615 mmol, 1.0 equiv.) in dichloromethane (DCM), N,N-dimethylformamide (DMF) (just 2-3 drops, ca. 0.05 equiv.) was added, followed by oxalyl chloride (COCl)2 (156 mg, 1.231 mmol, 2.0 equiv.) at 0°C. The reaction mixture was stirred at room temperature under argon atmosphere for 2 h. The progress of the reaction was monitored by TLC. The reaction mixture was evaporated and co-distilled with toluene (2.0 mL). Finally, the residue was dried by vacuum for 2 h to obtain compound (5). The obtained compound (5) was used as it was in the next operation.

[0240] In an oven-dried Schlenk tube, 1,2-dibromoethane (0.050 mL, just 1-2 drops) was added to a mixture containing magnesium turnings (30 mg, 1.231 mmol, 2.0 equiv.) and THF (3 mL, 10 volumes) under argon atmosphere. Then, 2-(5-bromo-2-fluorobenzyl)benzo[b]thiophene (197 mg, 0.615 mmol, 1.0 equiv.) was added under argon atmosphere. The reaction mixture was then refluxed at 75-80°C for 3 hours. After cooling to room temperature, the reaction mixture was transferred to another Schlenk tube using THF (1 mL x 2). Thus, the Grignard reagent was prepared.

[0241] In another oven-dried Schlenk tube, a THF solution of compound (5) (2 mL x 1) was added to a suspension of CuCN (55 mg, 0.615 mmol, 1.0 equiv.) and THF (1 mL) at -15°C. The Grignard reagent prepared above was added dropwise to the resulting reaction mixture over 30 min at -15°C and stirred at -15°C for 2 h. The progress of the reaction was monitored by TLC. The reaction was quenched with water (0.5 mL, 2 volumes). The reaction mixture was filtered through a Celite pad and the bed was washed with ethyl acetate (10 mL x 2). The filtrate was dried over anhydrous sodium sulfate and filtered. The solvent was removed by vacuum to obtain the crude compound. The crude compound was purified by silica gel column chromatography (ethyl acetate / n-hexane = 1 / 9 to 4 / 6) to obtain 256 mg (66% yield) of compound (1C') as an off-white fluffy solid.

[0242] The analytical results of the obtained compound (1C') are shown below. 1 H NMR(500MHz, CDCl3, 25℃):δ 7.95(dd,J=7.1,2.3Hz,1H),7.86(ddd,J=8.5,4.9,2.3Hz,1H),7.75-7.72(m,1H),7.66(dd,J=7.3,0.8H z,1H),7.32-7.28(m,1H),7.28-7.24(m,1H),7.17(t,J=8.9Hz,1H),7.04(s,1H),6.05(d,J=5.1Hz,1H),5 .72-5.66(m,1H),5.45(dd,J=6.8,4.5Hz,1H),5.11-5.04(m,1H),4.30(dd,J=19.8,9.3Hz,2H),4.26-4.2 3(m,1H),4.00(dd,J=12.5,5.9Hz,1H),2.09(s,3H),2.03(s,3H),2.02(s,3H),2.02(s,3H),1.93(s,3H). 13C NMR (126 MHz, CDCl3, 25°C): δ 191.74,170.80,169.92,169.79,169.74,169.54,165.23,163.19,142.36,140.01,139.80,132.10,132.06,131.49,129.79,129.71,127.83,127.70,124.38,124.03,123.22,122.39,122.21,116.43,116.24,72.44,69.49,68.82,68.65,61.77,29.82,20.80,20.75,20.56,20.42,20.36.

[0243] Example 6 Compound (2C) was produced from compound (1C') according to the following reaction scheme. Compound (2C) is (2S,3R,4S,5S,6R)-2-(3-(benzo[b]thiophen-2-ylmethyl)-4-fluorophenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol, i.e., an intermediate of ipragliflozin.

[0244] [ka]

[0245] A solution (1.5 mL) of methanesulfonic acid (MSA) (107 μL, 1.664 mmol) in methanol (MeOH) was added dropwise to a solution (1 mL) of compound (1C') (150 mg, 0.237 mmol) in tetrahydrofuran (THF) at -15°C, and the mixture was slowly brought to room temperature and stirred at room temperature for 12 hours. Completion of the reaction was confirmed by TLC. Ethyl acetate (10 mL) and aqueous sodium bicarbonate solution (5 mL) were added to the reaction mixture to quench the reaction. The organic layer was then separated, dried over sodium sulfate, and concentrated by vacuum pumping to obtain a crude compound. The obtained crude compound was purified by silica gel column chromatography (methanol / chloroform = 0.5 / 9.5 to 1 / 9) to obtain 67 mg (yield 65%) of compound (2C) as an off-white solid.

[0246] The analytical results of the obtained compound (2C) are shown below. 1 H NMR(500MHz, CDCl3, 25℃):δ 7.60(d,J=8.0Hz,1H),7.53(d,J=7.9Hz,1H),7.44(d,J=7.2Hz,1H),7.33 -7.30(m,1H),7.21-7.16(m,1H),7.16-7.10(m,1H),6.94-6.88(m,2H),5. 33(s,1H),5.17(s,1H),4.23-4.04(m,3H),3.92-3.70(m,3H),3.60(t,J= 8.9Hz,1H),3.47(d,J=9.6Hz,1H),3.34(s,1H),3.19(s,1H),2.84(s,3H). 13 C NMR(126MHz, CDCl3, 25℃):δ 159.87,143.64,140.03,140.02,140.01,140.00,139.64,139.62,139.60,134.06,134.03,126.23,126.10,124.27,123.81,123. 08,122.15,121.71,121.68,101.08,77.34,77.08,76.89,74.77,74.75,72.65,70.07,61.90,61.88,61.87,61.86,49.20,30.32.

[0247] Example 7 Compound (3C) was produced from compound (2C) according to the following reaction scheme. Compound (3C) is (2S,3R,4R,5S,6R)-2-(3-(benzo[b]thiophen-2-ylmethyl)-4-fluorophenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, i.e., ipragliflozin.

[0248] [ka]

[0249] To a solution (1.5 mL) of compound (2C) (60 mg, 0.130 mmol) in dichloromethane (CH2Cl2), triethylsilane (TES) (44 μL, 0.276 mmol) was added dropwise at -15°C, followed by slow addition of boron trifluoride diethyl ether complex (BF3·Et2O) (39 mg, 0.276 mmol) over 10 min and stirring at -10°C for 1 h. The progress of the reaction was monitored by TLC. The reaction mixture was diluted with ethyl acetate (10 mL) and quenched by adding saturated aqueous sodium bicarbonate (5 mL) to adjust the pH to 7-8. The organic layer was separated, washed with water (5 mL), dried over sodium sulfate, and filtered. The organic layer was concentrated by vacuum at 40-50°C to give a crude residue. The crude residue was purified by column chromatography (methanol / chloroform=1 / 9) to give 41 mg (73% yield) of compound (3C) as a white solid.

[0250] The analytical results of the obtained compound (3C) are shown below. 1 H NMR(500MHz,DMSO-d6,25℃):δ 7.85(d,J=8.1Hz,1H),7.74(d,J=7.5Hz,1H),7.41(dd,J=7.5,2.1Hz,1H),7.35-7.2 4(m,3H),7.16(t,J=9.2Hz,2H),4.93(d,J=5.2Hz,2H),4.80(d,J=5.7Hz,1H),4.44( t,J=5.8Hz,1H),4.26(q,J=15.6Hz,2H),4.02(d,J=9.4Hz,1H),3.72(tdd,J=11.7,5 .3,1.7Hz,1H),3.46(dt,J=11.8,5.9Hz,1H),3.31-3.22(m,2H),3.21-3.12(m,2H). 13C NMR(126MHz,DMSO-d6,25℃):δ 160.75,158.81,143.98,139.79,139.09,136.96,130.72,130.69,128.52,128.46,125.74,125.62,124 .50,124.00,123.23,122.41,121.80,114.89,114.72,81.40,80.87,78.53,74.91,70.52,61.55,29.69. HRMS: [M+Na] + C 21 H 21 O5FNa Calculated value: 427.0985, Measured value: 427.0986.

[0251] <Production Example 3> According to the following reaction scheme, compound (5) was produced from compound (4), and compound (1D') was produced from compound (5). Compound (1D') is (2R,3R,4S,5R)-6-(4-chloro-3-(4-(((R)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-oxohexane-1,2,3,4,5-pentyl pentaacetate.

[0252] [ka]

[0253] To a solution (3 mL) of compound (4) (250 mg, 0.615 mmol, 1.0 equiv.) in dichloromethane (DCM), N,N-dimethylformamide (DMF) (just 2-3 drops, ca. 0.05 equiv.) was added, followed by oxalyl chloride (COCl)2 (156 mg, 1.231 mmol, 2.0 equiv.) at 0°C. The reaction mixture was stirred at room temperature under argon atmosphere for 2 h. The progress of the reaction was monitored by TLC. The reaction mixture was evaporated and co-distilled with toluene (2.0 mL). Finally, the residue was dried by vacuum for 2 h to obtain compound (5). The obtained compound (5) was used as it was in the next operation.

[0254] In an oven-dried Schlenk tube, 1,2-dibromoethane (0.050 mL, just 1-2 drops) was added to a mixture containing magnesium turnings (30 mg, 1.231 mmol, 2.0 equiv.) and tetrahydrofuran (THF) (3 mL, 10 volumes) under argon atmosphere. (R)-3-(4-(5-bromo-2-chlorobenzyl)phenoxy)tetrahydrofuran (226 mg, 0.615 mmol, 1.0 equiv.) was then added under argon atmosphere. The reaction mixture was then refluxed at 75-80°C for 3 hours. After cooling to room temperature, the reaction mixture was transferred to another Schlenk tube using THF (1 mL x 2). Thus, the Grignard reagent was prepared.

[0255] In another oven-dried Schlenk tube, a THF solution of compound (5) (2 mL x 1) was added to a suspension of CuCN (55 mg, 0.615 mmol, 1.0 equiv.) and THF (1 mL) at -15°C. The Grignard reagent prepared above was then added dropwise to the reaction mixture over 30 min at -15°C and stirred at -15°C for 1 h. The progress of the reaction was monitored by TLC. The reaction was quenched with water (0.5 mL, 2 volumes). The reaction mixture was filtered through a Celite pad and the bed was washed with ethyl acetate (10 mL x 2). The filtrate was dried over anhydrous sodium sulfate and filtered. The solvent was removed by vacuum to obtain the crude compound. The crude compound was purified by silica gel column chromatography (ethyl acetate / n-hexane = 1 / 9 to 4 / 6) to obtain 234 mg (72% yield) of compound (1D') as an off-white fluffy solid.

[0256] The analytical results of the obtained compound (1D') are shown below. FTIR(NaCl):2997,1680,1509,1372,1218,1045cm -1 ; 1H NMR(500MHz, CDCl3, 25℃):δ 7.74(d,J=2.1Hz,1H),7.72(d,J=2.2Hz,1H),7.70(d,J=2.2Hz,1H),7.12-7.08(m,1H),6.82-6.77 (m,1H),6.00(d,J=5.2Hz,1H),5.67(dd,J=5.1,4.3Hz,1H),5.45(dd,J=7.0,4.3Hz,1H),5.13-5.0 6(m,1H),4.95-4.82(m,1H),4.30(dd,J=12.5,3.0Hz,1H),4.13-4.06(m,3H),4.00-3.92(m,3H),3 .89(dd,J=8.2,4.5Hz,1H),2.23-2.11(m,2H),2.10(s,3H),2.05(s,3H),2.04(s,6H),1.93(s,3H). 13 C NMR(126MHz, CDCl3, 25℃):δ 192.45,170.72,169.88,169.72,169.52,156.18,140.33,140.09,133.63,131.03,131.00,130.17,130.07,130.06,127.57,115 .60,115.59,115.58,77.39,73.16,72.44,69.39,68.74,68.57,67.24,61.80,38.36,33.07,20.81,20.73,20.58,20.42,20.36. HRMS: [M+Na] + C 33 H 37 O 13 NaCl Calculated: 699.1815, Found: 699.1823.

[0257] Example 9 Compound (2D) was produced from compound (1D') according to the following reaction scheme: Compound (2D) is (2S,3R,4S,5S,6R)-2-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol, i.e., an empagliflozin intermediate.

[0258] [ka]

[0259] A solution of sulfuric acid (H2SO4) (63μL, 1.181mmol) in methanol (MeOH) (2mL) was added dropwise to a solution of compound (1D') (100mg, 0.147mmol) in tetrahydrofuran (THF) (1mL) at -15℃, and the mixture was stirred at -15℃ for 2 hours, then slowly brought to room temperature and stirred at room temperature for 12 hours. Completion of the reaction was confirmed by TLC. Ethyl acetate (10mL) and aqueous sodium bicarbonate solution (10mL) were added to the reaction mixture to quench the reaction. The organic layer was then separated, dried over sodium sulfate, and concentrated by vacuum to obtain the crude product as a sticky off-white solid. The obtained crude product was purified by column chromatography (methanol / chloroform=0.5 / 9.5) to obtain 47mg (66% yield) of compound (2D) as an off-white amorphous solid.

[0260] The analytical results of the obtained compound (2D) are shown below. 1 H NMR(500MHz, CDCl3, 25℃):δ 7.34(s,1H),7.24(d,J=8.3Hz,1H),7.20(d,J=8.2Hz,1H),7.03(d,J=8.5Hz,2H),6.68 (d,J=8.5Hz,2H),5.18(s,1H),5.07(s,1H),4.78(s,1H),4.22(s,1H),4.03-3.88(m,3 H),3.84(t,J=7.1Hz,3H),3.82-3.75(m,3H),3.56(t,J=9.0Hz,1H),3.49(d,J=9.5Hz, 1H),3.36(s,1H),3.17(d,J=8.8Hz,1H),2.84(s,3H),2.63(bs,2H),2.15-1.99(m,2H).

[0261] Example 10 Compound (2D) was produced from compound (1D') according to the following reaction scheme.

[0262] [ka]

[0263] A solution of methanesulfonic acid (MSA) (195 μL, 2.20 mmol, 5.0 equiv.) in methanol (MeOH) (3 mL) was added dropwise to a solution of compound (1D') (300 mg, 0.44 mmol, 1.0 equiv.) in tetrahydrofuran (THF) (1.5 mL) at -15°C, and the mixture was stirred at -15°C for 2 hours, then slowly brought to room temperature and stirred for 12 hours. Since TLC showed that the reaction was not complete (unconsumed compound (1D') remained), additional MSA (78 μL, 0.88 mmol, 2.0 equiv.) was added to the reaction mixture, which was further stirred for an additional 12 hours, and the reaction was completed by TLC. Ethyl acetate (10 mL) and aqueous sodium bicarbonate (10 mL) were added to the reaction mixture. The organic layer was then separated, dried over sodium sulfate, and concentrated by vacuum. The resulting crude compound was purified by silica gel column chromatography (SiO2 230-400 eluted with 30% ethyl acetate in hexane) to give purified compound (2D) (166 mg, yield 78%) as a sticky solid.

[0264] The analytical results of the obtained compound (2D) are shown below. 1 H NMR(500MHz,CDCl3):δ 7.34(s,1H),7.23-7.18(m,2H),7.01(d,J=8.0Hz,2H),6.66(d,J=8.0Hz,2H),5.21(s,1H),5.07(s,1H),4.76( s,1H),4.24(s,1H),3.99-3.76(m,9H),3.57-3.47(m,2H),3.16(d,J=8Hz,1H),2.83(s,3H),2.08-2.05(m,2H).

[0265] Example 11 Compound (3D) was produced from compound (2D) according to the following reaction scheme: Compound (3D) is (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, i.e., empagliflozin.

[0266] [ka]

[0267] To a solution of compound (2D) (72 mg, 0.15 mmol, 1 equiv.) in dichloromethane (CH2Cl2) (1.5 mL), triethylsilane (TES) (51 μL, 0.318 mmol, 2 equiv.) was added dropwise at -15°C, and boron trifluoride diethyl ether complex (BF3·Et2O) (67 mg, 0.318 mmol, 2 equiv.) was added slowly over 10 min, and the mixture was stirred at -10°C for 1 h. The progress of the reaction was monitored by TLC. After completion of the reaction, the reaction mixture was diluted with ethyl acetate (10 mL) and quenched by adding saturated aqueous sodium bicarbonate (5 mL) to adjust the pH to 7-8. The organic layer was separated, washed with water (5 mL), dried over sodium sulfate, and filtered. The combined organic layers were concentrated under vacuum at 40-50°C to give the crude product as a solid. The crude product was crystallized using ethyl acetate (2 mL) and hexane (10 mL). The crystals were filtered, washed with hexane, and dried to give the final product, compound (3D) (59 mg, 88% yield) as a white solid.

[0268] The analytical results of the obtained compound (3D) are shown below. 1 H NMR(500MHz,CDCl3):δ 7.24-7.10(m,3H),7.03-6.98(m,2H),6.69-6.64(m,2H),5.15-4.95(m,2H),4.70(s,1H),4.10-2.93(m,15H),2.04-2.01(m,2H).

[0269] Example 12 Compound (3D) was produced from compound (2D) according to the following reaction scheme.

[0270] [ka]

[0271] To a solution of compound (2D) (48 mg, 0.10 mmol, 1 equiv.) in anhydrous dichloromethane (CHCl) (1.0 mL), triethylsilane (TES) (51 μL, 0.20 mmol, 2 equiv.) was added dropwise at -15°C, followed by slow addition of boron trifluoride tetrahydrofuran complex (BF3·THF) (28.0 mg, 0.20 mmol, 2 equiv.) over 10 min, and the mixture was stirred at 0°C for 1 h. The progress of the reaction was monitored by TLC. After completion of the reaction, the reaction mixture was diluted with ethyl acetate (10 mL) and quenched by adding saturated aqueous sodium bicarbonate (5 mL) to adjust the pH to 7-8. The organic layer was separated, washed with water (5 mL), dried over sodium sulfate, and filtered. The combined organic layers were concentrated under vacuum at 40-50°C to give the crude product as a solid. The crude product was crystallized using ethyl acetate (2 mL) and hexane (10 mL). The crystals were filtered, washed with hexane, and then dried to give the final product, compound (3D) (33.8 mg, 75% yield) as a white solid.

[0272] The analytical results of the obtained compound (3D) are shown below. 1 H NMR(500MHz,DMSO-D6):δ 7.35-7.25(m,2H),7.20-7.16(m,1H),7.09-7.06(m,2H),6.80(d,J=8.5Hz,2H),4.92-4.90(m,3H),4.78(d,J=5.0Hz,1H ),4.40(t,J=6.0Hz,1H),3.98-3.66(m,8H),3.45-3.40(m,1H),3.26-3.06(m,4H),2.18-2.11(m,1H),1.92-1.87(m,1H).

Claims

1. The following formula (III): 【Chemistry 1】 [In the formula, Ar represents an optionally substituted alkyl group, an optionally substituted alkenyl group, an optionally substituted cycloalkyl group, an optionally substituted heterocycloalkyl group, an optionally substituted aryl group, an optionally substituted heteroaryl group, an optionally substituted arylalkyl group, or an optionally substituted arylalkenyl group; R 100 represents an alkyl group which may have a substituent. A method for producing compound (III) represented by the following formula: The following formula (Ia): 【Chemistry 2】 [In the formula, R each independently represents an alkyl group which may have a substituent or an aryl group which may have a substituent; Ar has the same meaning as above. Compound (Ia) represented by the formula: The following formula (Ib): 【Chemistry 3】 [In the formula, R and Ar are as defined above.] Compound (Ib) represented by the formula: Compound (I) selected from Acid, The following formula (II): 【Chemistry 4】 [In the formula, R 100 has the same meaning as above.] in a solvent containing an alcohol (II) represented by the following formula (III):

2. The method according to claim 1, wherein the compound (I) and the acid are contacted in the solvent at a temperature of -80°C or higher and 40°C or lower.

3. The method according to claim 1 or 2, wherein the alcohol (II) is an alcohol having 1 to 5 carbon atoms.

4. The method according to claim 3, wherein the alcohol (II) is methanol.

5. The acid is represented by the following formula (IV): 【Chemistry 5】 [In the formula, R 200 represents an alkyl group which may have a substituent or an aryl group which may have a substituent. The method according to claim 1 or 2, wherein the compound (IV) is represented by the formula:

6. 3. The method of claim 1 or 2, wherein the acid is sulfuric acid.

7. The following formula (V): 【Chemistry 6】 [In the formula, Ar has the same meaning as defined above.] A method for producing a compound (V) represented by the following formula: A method comprising the steps of producing compound (III) by the method according to claim 1 or 2, and then contacting the produced compound (III) with a silane compound in the presence of a Lewis acid to produce compound (V).

Citation Information

Patent Citations

  • Process for the preparation of compounds useful as inhibitors of SGLT

    WO2010043682A2

  • Methods and compounds for treating paramyxoviridae virus infections

    WO2012012776A1

  • Method for manufacturing c-glycoside derivative

    WO2015012110A1